se
ge
lh
k
j
k
ca
n
veterinari
diseas
biolog
univers
copenhagen
frederiksberg
clinic
studi
school
veterinari
medicin
univers
pennsylvania
philadelphia
pa
usa
pathobiolog
school
veterinari
medicin
univers
pennsylvania
philadelphia
pa
usa
clinic
scienc
faculti
veterinari
medicin
anim
scienc
swedish
univers
agricultur
scienc
uppsala
nation
de
la
et
de
la
recherch
inserm
institut
de
de
rangueil
toulous
franc
heighten
serotonin
signal
postul
develop
andor
progress
myxomat
mitral
valv
diseas
mmvd
dog
littl
known
regard
platelet
myocardi
valvular
concentr
affect
dog
sought
quantifi
prp
plasma
ppp
left
ventricular
myocardium
lv
mitral
valv
leaflet
tissu
mv
use
hplc
pppprp
prepar
dog
compris
differ
plasma
group
healthi
king
charl
spaniel
ckc
n
healthi
ckc
n
mmvd
ckc
n
mmvd
n
prp
greater
ppp
p
indic
platelet
primari
sourc
circul
median
prp
platelet
significantli
differ
group
p
prp
greater
femtogramsplatelet
p
p
p
vs
signific
differ
median
ppp
group
euthanasia
lv
mv
tissu
obtain
dog
compris
differ
tissu
group
mmvd
n
dilat
cardiomyopathi
dcm
arrhythmogen
right
ventricular
cardiomyopathi
arvc
n
diseas
n
median
lv
significantli
differ
p
group
lv
higher
vs
p
vs
p
mv
significantli
differ
group
p
name
vs
p
conclus
platelet
elev
healthi
mmvd
ckc
compar
healthi
lv
elev
mmvd
compar
dcmarvc
diseas
mv
elev
mmvd
compar
diseas
pr
ip
ar
fo
v
de
ab
ej
r
oliveira
veterinari
anim
scienc
feder
univers
univers
rio
de
janeiro
brazil
lassbio
new
prototyp
drug
produc
safrol
substrat
compound
extract
sassafra
oil
found
brazilian
plant
like
ocotea
pretiosa
show
vasodilatori
effect
vitro
aorta
normotens
rat
vivo
test
rat
develop
evalu
synthesi
bioactiv
substanc
laboratori
feder
univers
rio
de
janeiro
believ
mechan
action
mediat
muscarin
receptor
subsequ
activ
nitric
oxidecycl
guanosin
monophosph
due
pharmacolog
profil
possibl
new
therapeut
strategi
investig
effect
cardiovascular
system
dog
held
thu
six
adult
beagl
five
femal
one
male
healthi
use
dog
subject
four
treatment
biweekli
interv
receiv
oral
specif
dose
mgkg
mgkg
mgkg
lassbio
mgkg
benazepril
posit
control
dog
underw
blood
urin
sampl
twelv
hour
oral
administr
prototyp
doppler
echocardiograph
electrocardiograph
examin
one
two
four
six
twelv
hour
oral
administr
blood
pressur
screen
fifteen
thirti
sixti
nineti
minut
two
four
six
twelv
hour
administr
dog
show
clinic
behavior
chang
studi
regard
urinari
hematolog
serum
biochem
evalu
although
statist
differ
time
observ
paramet
remain
within
refer
valu
speci
similar
result
obtain
pereira
et
al
studi
administ
benazepril
dog
heart
rhythm
abnorm
doppler
echocardiograph
evalu
valu
obtain
stroke
volum
sv
cardiac
output
co
lower
describ
normal
dog
lowest
valu
found
four
sv
ml
co
lmin
six
sv
ml
co
lmin
hour
administr
assess
systol
blood
pressur
decreas
observ
two
hour
p
three
dose
lassbio
administ
similar
result
obtain
administr
benazepril
demonstr
molecul
potenti
vasodilatori
activ
addit
safeti
sinc
hypotens
occur
consid
result
obtain
condit
experi
conduct
conclud
oral
administr
lassbio
dose
mgkg
mgkg
mgkg
caus
side
effect
healthi
beagl
demonstr
prototyp
drug
safe
dose
caus
vasodil
two
hour
administr
similar
observ
benazepril
drug
extens
use
treat
hypertens
dog
u
bristol
bristol
helsinki
helsinki
zurich
zurich
switzerland
littl
known
role
myocardi
inflamm
remodel
cardiac
dysfunct
particular
associ
system
diseas
age
myocardi
sampl
interventricular
septum
right
left
atrium
ventricl
cat
system
diseas
group
cat
fip
group
cat
cardiac
diseas
group
cat
without
system
cardiac
diseas
group
collect
cat
group
addit
separ
age
group
year
age
transcript
level
felin
interleukin
il
tumour
necrosi
tnf
ifn
transform
growth
tgf
matrix
metalloproteinas
mmp
tissu
inhibitor
metalloproteinas
timp
analys
relat
hous
keep
gene
gapdh
use
real
time
transcript
ifn
highest
group
p
tnf
tgf
group
p
mrna
concentr
differ
group
higher
group
p
region
differ
mrna
express
detect
cat
group
young
cat
show
higher
transcript
level
p
wherea
tgf
increas
age
p
myocardi
mrna
express
marker
inflamm
remodel
similar
cat
system
cardiac
diseas
suggest
impact
system
diseas
cardiac
function
furthermor
age
might
influenc
cardiac
inflamm
remodel
sa
jesti
sm
john
b
potter
e
berger
im
asif
univers
tennesse
knoxvil
tn
purpos
studi
determin
whether
intens
exercis
train
dog
lead
ventricular
remodel
increas
suscept
malign
arrhythmia
sudden
cardiac
death
scd
lead
caus
death
exert
peopl
occur
also
anim
athlet
hors
dog
unfortun
factor
explain
phenomenon
essenti
unknown
investig
need
understand
mechan
scd
endur
activ
order
improv
outcom
peopl
anim
repeat
measur
design
pilot
studi
laboratori
beagl
dog
serv
control
dog
underw
baselin
vivo
electrophysiolog
ep
test
assess
suscept
trigger
ectop
ventricular
activ
particip
week
exercis
condit
program
treadmil
run
day
per
week
minut
per
day
mph
grade
underw
repeat
vivo
ep
test
assess
effect
endur
exercis
arrhythmia
induc
baselin
dog
induc
arrhythmia
ep
test
week
exercis
program
dog
display
clear
induc
ventricular
arrhythmia
ep
test
trigger
arrhythmia
appear
right
ventricular
origin
although
clear
benefit
moder
intens
exercis
intens
endur
exercis
train
may
promot
advers
cardiac
remodel
act
substrat
malign
arrhythmia
understand
scd
mechan
may
lead
enhanc
prevent
resuscit
strategi
jr
payn
v
lui
fuent
dc
brodbelt
royal
veterinari
colleg
hatfield
hertfordshir
unit
kingdom
preval
cardiac
murmur
hypertroph
cardiomyopathi
hcm
investig
cat
rehom
center
month
period
use
auscult
echocardiographi
hcm
defin
diastol
left
ventricular
lv
septal
free
wall
thick
mm
cat
consid
elig
age
exclud
hypertens
hyperthyroid
pregnant
clinic
sign
nervousaggress
examin
one
oper
jrp
auscult
measur
blood
pressur
scan
cat
elig
cat
complet
protocol
median
rang
age
group
categor
rang
though
cat
cat
median
rang
bodi
weight
kg
male
murmur
detect
first
auscult
cat
gallop
heard
cat
arrhythmia
cat
hcm
diagnos
systol
anterior
motion
mitral
valv
sam
preval
hcm
increas
age
p
posit
predict
valu
ppv
murmur
detect
hcm
singl
auscult
juvenil
cat
senior
cat
respect
neg
predict
valu
npv
murmur
hcm
extrem
common
gener
cat
popul
mani
cat
murmur
normal
wall
thick
particularli
young
ppv
murmur
indic
hcm
hcm
preval
increas
age
dg
ohad
e
golani
koret
school
veterinari
medicin
hebrew
univers
jerusalem
rehovot
israel
pulmonari
hypertens
ph
may
present
hard
quantifi
even
identifi
absenc
tricuspid
pulmonari
insuffici
sought
find
measur
chang
doppler
paramet
systol
blood
flow
semilunar
heart
valv
dog
ph
secondari
mitral
valv
diseas
mvd
without
pimobendan
therapi
data
retrospect
obtain
consecut
mvd
dog
examin
doppler
evid
ph
dog
sort
group
base
whether
n
n
pimobendan
includ
therapi
absenc
pimobendan
therapi
aortic
acct
aortic
et
aortic
acctet
decreas
significantli
time
potenti
due
higher
system
afterload
decreas
cardiac
output
due
progress
ph
dog
receiv
pimobendan
pulmonari
acctet
decreas
lesser
extent
along
time
dog
pimobendan
therapi
nevertheless
pimobendan
unequivoc
proven
reduc
right
ventricular
afterload
per
spectral
doppler
imag
reason
may
enhanc
right
ventricular
stroke
volum
follow
inodil
reduc
afterload
progress
natur
underli
mvd
along
complic
includ
progress
ph
larger
prospect
studi
includ
systol
time
interv
may
establish
whether
imped
semilunar
valv
progress
decreas
time
without
therapi
c
amberg
e
mottet
brizard
riesen
c
lombard
imavet
center
geneva
vetsuiss
univers
bern
switzerland
sphynx
cat
predispos
hypertroph
cardiomyopathi
hcm
suspect
autosom
domin
mode
inherit
incomplet
penetr
object
report
character
heart
morphometri
sphynx
hcm
base
retrospect
evalu
patient
echocardiograph
measur
clinic
evolut
pedigre
analysi
necropsi
find
evalu
base
normal
valu
sphynx
hcm
diagnos
convent
echocardiographi
use
ci
interventricular
septum
free
wall
mean
mm
limit
normal
hcm
abnorm
examin
diagnosi
hcm
follow
year
age
affect
cat
rang
year
median
age
onset
clinic
sign
rang
year
median
echocardiograph
morphometri
lv
hypertrophi
confirm
necropsi
find
histolog
chang
similar
observ
previous
done
domest
shorthair
main
coon
cat
sign
myocard
found
two
cat
acut
congest
heart
failur
posit
pcr
coronaviru
result
report
suggest
autosom
domin
mode
inherit
hcm
cat
diagnos
equivoc
wall
thick
mm
ci
mm
age
month
confirm
develop
hcm
mm
age
year
cat
still
aliv
year
diagnosi
develop
clinic
symptom
left
atrial
dilat
die
heart
failur
remain
asymptomat
n
van
anim
cardiopulmonari
consult
acapulco
masta
belgium
toxoplasma
gondii
infect
nearli
anim
consequ
passag
intermedi
eg
dog
definit
host
cat
often
underestim
object
studi
retrospect
describ
clinic
patholog
featur
emphasi
cardiorespiratori
system
larg
popul
natur
occur
toxoplasmosi
acut
toxoplasmosi
defin
anim
posit
igm
titer
fourfold
seroconvalesc
igg
titer
week
period
determin
ifa
elisa
techniqu
dog
cat
fulfil
criteria
specif
breed
gender
predisposit
age
rang
wide
cat
median
dog
median
anorexia
lethargi
main
present
sign
cat
dog
exercis
intoler
experienc
breathless
cough
syncop
electrocardiographi
present
dog
first
second
third
degre
dog
supraventricular
arrhythmia
dog
af
atrial
flutter
svt
radiograph
find
rang
pulmonari
pattern
alveolar
aspir
infiltr
cardiac
patholog
cardiomegali
congest
heart
failur
normal
set
rx
avail
echocardiographi
normal
anim
show
sign
might
consist
myocard
anim
two
dog
develop
pericardi
one
pleural
effus
neutrophilia
frequent
hematolog
abnorm
follow
mildli
elev
hct
elev
liver
enzym
common
biochem
find
follow
increas
cpk
toxoplasmosi
igm
titer
initi
present
median
elev
cat
seroconvert
igg
week
period
could
take
month
complet
disappear
igm
titer
median
month
two
dog
titer
time
troponin
level
avail
dog
elev
rang
proteinuria
initi
present
featur
dog
cat
final
clinic
diagnosi
consist
myocard
anim
hepatopathi
tracheobronchitispneumonitispneumonia
pericard
chorioretin
plnp
laryng
paralysi
accompani
megaoesophagu
pleuriti
polyarthr
polymyopathi
sialoden
respect
nearli
anim
treat
clindamycin
first
choic
stmp
doxycyclin
second
choic
three
dog
die
suddenli
treatment
euthan
cat
complic
diseas
make
diseas
inoffens
wide
describ
sg
ab
r
mw
michael
e
debakey
institut
colleg
veterinari
medicin
biomed
univers
colleg
station
inform
network
davi
varieti
devic
use
transcathet
occlus
patent
ductu
arteriosu
pda
veterinari
medicin
includ
variou
type
embol
coil
vascular
plug
occlud
immedi
delay
day
embol
system
pulmonari
circul
report
complic
transcathet
pda
occlus
regardless
devic
type
use
embol
typic
thought
occur
result
inappropri
devic
size
oper
error
veterinari
studi
assess
devic
efficaci
complic
rate
rel
small
make
statist
unlik
catch
rare
import
complic
report
base
result
survey
design
assess
type
rate
detail
complic
includ
embol
associ
transcathet
pda
occlus
addit
report
detail
prefer
method
pda
size
estim
ductal
occlud
select
procedur
practic
use
transesophag
echocardiographi
initi
survey
respond
indic
varieti
devic
includ
canin
ductal
occlud
coil
vascular
plug
use
transcathet
occlus
preliminari
survey
result
six
procedur
result
embol
five
six
one
discharg
hospit
two
six
cat
devic
vascular
plug
remain
devic
canin
ductal
occlud
two
death
one
death
associ
attempt
retriev
vascular
plug
cat
consequ
acut
heart
failur
follow
delay
embol
ductal
occlud
respond
report
use
fluoroscopi
angiographi
addit
transesophag
echocardiographi
frequent
use
adjunct
imag
procedur
sb
gs
mw
l
jf
rd
veterinari
medicin
agricultur
food
natur
resourc
univers
missouri
columbia
mo
purpos
character
famili
dilat
cardiomyopathi
dcm
standard
schnauzer
sss
identifi
causal
mutat
retrospect
evalu
reveal
dcm
relat
sss
confirm
via
echocardiographi
necropsi
examin
pedigre
contain
dcm
confirm
case
suggest
autosom
recess
mode
inherit
averag
coverag
whole
genom
sequenc
wg
gener
dna
male
ss
die
month
age
dcm
congest
heart
failur
wg
contain
homozyg
sequenc
variant
predict
alter
primari
structur
gene
product
absent
wgss
canid
exhibit
dcm
bp
delet
frame
shift
exon
sequenc
variant
consid
like
causal
mutat
human
rodent
ortholog
caus
dcm
eight
confirm
dcm
case
dna
avail
test
homozyg
delet
allel
deldel
prospect
screen
mutat
identifi
sss
homozyg
wild
type
allel
sss
heterozyg
addit
sss
homozyg
delet
allel
two
deldel
sss
subsequ
diagnos
occult
dcm
via
echocardiographi
echocardiograph
evalu
sss
heterozyg
delet
allel
includ
year
old
ss
reveal
echocardiograph
evid
myocardi
dysfunct
conclud
homozyg
bp
delet
like
caus
famili
dcm
sss
ba
ga
r
rd
veterinari
clinic
scienc
ohio
state
univers
columbu
radiolog
ohio
state
univers
wexner
medic
center
columbu
oh
singl
coronari
arteri
anomali
scaa
recogn
bulldog
character
prepulmon
cours
limit
abil
interven
set
pulmonari
valv
stenosi
ps
standard
care
defin
coronari
arteri
anatomi
requir
left
heart
catheter
gener
anesthesia
investig
abil
new
gener
ct
scanner
visual
coronari
arteri
circul
bulldog
consciou
sedat
ten
bulldog
prospect
enrol
one
ps
sedat
includ
dexmedetomidin
butorphanol
limit
movement
atropin
administ
need
normal
cycl
length
dog
intub
remain
consciou
imag
dog
imag
ct
scanner
flash
siemen
medic
system
erlangen
germani
iodin
contrast
isovu
mlkg
deliv
iv
scan
time
peak
aortic
opacif
structur
function
reconstruct
made
left
heart
visual
coronari
circul
throughout
cardiac
cycl
possibl
dog
even
heart
rate
per
minut
scaa
prepulmon
left
coronari
arteri
observ
dog
without
ps
coronari
arteri
anatomi
dog
ps
clearli
delin
impact
catheter
plan
report
noninvas
protocol
consciou
sedat
determin
coronari
arteri
anatomi
breed
dog
risk
scaa
exist
scaa
otherwis
normal
bulldog
suggest
scaa
may
caus
etiolog
ps
bulldog
previous
suggest
ja
nm
lb
km
medicin
epidemiolog
school
veterinari
medicin
univers
california
davi
davi
veterinari
clinic
scienc
colleg
veterinari
medicin
north
carolina
state
univers
raleigh
molecular
biomed
scienc
colleg
veterinari
medicin
north
carolina
state
univers
raleigh
medic
cancer
center
pet
worthington
oh
subvalvular
aortic
stenosi
newfoundland
describ
famili
diseas
autosom
domin
pattern
inherit
associ
mutat
report
newfoundland
dog
recruit
genet
studi
sa
dog
left
ventricular
outflow
tract
lvot
veloc
exceed
msec
consid
sa
affect
compar
control
veloc
msec
fresh
lvot
tissu
obtain
two
sever
affect
newfoundland
sa
rna
sequenc
analysi
rnaseq
perform
sa
tissu
dog
sampl
without
sa
singl
codon
insert
identifi
phosphatidylinositol
bind
clathrin
assembl
protein
picalm
segreg
diseas
statu
newfoundland
signific
downstream
structur
chang
predict
mutant
picalm
protein
loss
function
propos
insert
center
breakpoint
necessari
format
picalm
fusion
complex
transcript
regul
insert
identifi
control
dog
vari
breed
picalm
primarili
involv
endocytosi
cellular
membran
day
xenopu
laevi
embryo
small
molecul
inhibit
clathrin
observ
abnorm
outflow
tract
morphogenesi
signific
abnorm
outflow
tract
morphogenesi
observ
immunohistochemistri
singl
codon
insert
picalm
alter
protein
associ
sa
develop
newfoundland
role
picalm
cardiac
morphogenesi
pathogenesi
yet
determin
howev
clathrin
inhibit
embryogenesi
might
observ
dysfunct
picalm
protein
demonstr
previous
unreport
role
endocytosi
outflow
tract
morphogenesi
jl
sauer
lm
freeman
je
rush
tuft
cum
school
veterinari
medicin
north
grafton
pathophysiolog
caus
degen
mitral
valv
diseas
dmvd
remain
unclear
although
number
way
diet
could
play
role
dmvd
includ
serotonin
pathway
dietari
factor
relat
develop
dvmd
investig
therefor
object
studi
measur
dietari
amino
acid
cholin
carnitin
serotonin
ergovalin
possibl
factor
could
play
role
pathophysiolog
dmvd
thirteen
diet
select
analysi
base
previou
studi
compar
dog
without
dmvd
diet
histori
clinic
case
diet
analyz
macronutri
amino
acid
ergovalin
indoleamin
melatonin
cholin
free
wide
rang
concentr
analyt
diet
test
essenti
amino
acid
associ
american
feed
control
offici
aafco
minimum
taurin
although
essenti
amino
acid
dog
aafco
cat
food
nutrient
profil
taurin
diet
tryptophan
rang
dri
matter
median
dri
matter
sampl
test
undetect
ergovalin
concentr
one
sampl
test
posit
melatonin
detect
diet
also
wide
variat
differ
respect
cholin
free
concentr
among
diet
addit
research
need
effect
vari
dietari
intak
tryptophan
amino
acid
cholin
carnitin
cardiac
valv
metabol
je
rush
lm
freeman
feugier
van
hoek
tuft
cum
school
veterinari
medicin
north
grafton
usa
royal
canin
sa
aimargu
franc
cat
hypertroph
cardiomyopathi
hcm
larger
higher
growth
concentr
cat
without
hcm
better
understand
relationship
growth
bodi
size
hcm
object
studi
assess
adult
cat
determin
whether
echocardiograph
find
left
ventricular
hypertrophi
lvh
relat
earli
growth
pattern
bodi
size
metabol
marker
adult
cat
singl
coloni
year
age
growth
curv
avail
elig
studi
physic
examin
echocardiographi
perform
bodi
weight
bodi
condit
score
bc
head
length
width
measur
circul
glucos
insulin
natriuret
peptid
nt
concentr
measur
growth
data
collect
stepwis
multivari
analysi
varianc
multivari
logist
regress
perform
neuter
adult
cat
male
femal
elig
studi
median
age
yr
rang
yr
current
bodi
condit
score
rang
median
bodi
weight
rang
kg
median
kg
cardiac
abnorm
includ
cardiac
murmur
n
gallop
n
arrhythmia
n
fourteen
cat
echocardiograph
evid
left
ventricular
hypertrophi
lvh
head
width
p
bodi
weight
p
nt
p
p
significantli
associ
measur
lvh
potenti
associ
bodi
size
lvh
hcm
warrant
futur
prospect
studi
k
j
univers
agricultur
scienc
uppsala
medic
scienc
uppsala
univers
uppsala
anim
hospit
danderyd
sweden
chromogranin
cga
store
secretori
cell
sympathet
nerv
end
adren
medulla
catecholamin
peptid
catestatin
act
sympathoinhibitori
stabil
molecul
plasma
make
interest
candid
assess
sympathet
nervou
system
human
cga
also
present
ventricular
myocardium
natriuret
peptid
bnp
aim
studi
investig
whether
plasma
catestatin
concentr
associ
myxomat
mitral
valv
diseas
mmvd
sever
dog
assess
potenti
associ
plasma
catestatin
concentr
dog
characterist
echocardiograph
variabl
heart
rate
hr
systol
blood
pressur
sbp
probnp
dog
mmvd
vari
sever
prospect
recruit
dog
classifi
accord
mmvd
sever
healthi
mild
moder
sever
diseas
three
dog
decompens
congest
heart
failur
chf
plasma
concentr
catestatin
analyz
use
radioimmunoassay
associ
catestatin
concentr
mmvd
sever
group
found
hr
higher
sever
affect
dog
healthi
mildli
affect
associ
catestatin
concentr
weak
neg
associ
left
atrial
ventricular
size
p
weak
posit
associ
sbp
p
found
catestatin
concentr
remain
variabl
present
studi
popul
catestatin
associ
sever
mmvd
hr
seem
better
indic
sympathet
tone
catestatin
includ
dog
decompens
chf
might
given
differ
result
e
mc
r
veterinari
colleg
univers
princ
edward
island
charlottetown
pe
veterinari
medicin
univers
montreal
st
hyacinth
qc
canada
current
diagnosi
subaort
stenosi
sa
dog
princip
reli
auscult
basilar
systol
heart
murmur
echocardiograph
echo
demonstr
abnorm
high
peak
left
ventricular
outflow
tract
blood
veloc
lvot
vmax
retrospect
studi
sought
identifi
associ
among
echo
determin
lvot
vmax
presenc
abnorm
aortosept
angl
aosa
left
ventricular
subendocardi
hyperechogen
lv
investig
possibl
associ
aosa
heart
murmur
equal
greater
intens
right
heart
base
compar
left
medic
record
golden
retriev
gr
seen
review
complet
echo
avail
cine
loop
cardiac
disord
sa
note
heart
murmur
point
maxim
intens
pmi
note
record
cardiologist
time
echo
aosa
determin
gr
lvot
vmax
ms
consid
normal
gr
lvot
vmax
ms
systol
basilar
heart
murmur
consid
sa
gr
neither
consid
equivoc
regress
analysi
use
investig
relationship
paramet
gr
met
entri
criteria
equivoc
aosa
lvot
vmax
invers
associ
increas
aosa
lvot
vmax
decreas
ms
p
dog
moder
lv
aosa
averag
less
dog
without
lv
p
signific
associ
aosa
heart
murmur
pmi
equal
loud
louder
right
rather
left
p
dog
aosa
mean
less
dog
murmur
pmi
left
sampl
associ
exist
among
paramet
associ
may
provid
clinic
use
inform
addit
lvot
vmax
evalu
gr
sa
av
chen
sa
thomovski
j
brune
n
boswel
jc
houl
washington
state
univers
colleg
veterinari
medicin
pullman
wa
diagnost
signific
cerebrospin
fluid
csf
lactat
dehydrogenas
ld
creatin
kinas
ck
activ
rel
unexplor
veterinari
medicin
csf
ld
ck
activ
shown
use
diagnosi
prognosi
mening
human
purpos
studi
determin
total
ld
ck
activ
isoenzym
distribut
csf
dog
idiopath
epilepsi
ie
primari
brain
tumor
pbt
mening
total
dog
enrol
pilot
studi
divid
three
group
ie
n
pbt
n
mening
n
csf
total
ld
ck
activ
measur
spectrophotometr
isoenzym
distribut
determin
use
gel
electrophoresi
densitometr
scan
mean
total
ld
activ
ul
ie
pbt
mening
respect
mean
contribut
contribut
ie
pbt
mening
respect
mean
total
ck
activ
ul
ie
pbt
mening
respect
mean
contribut
contribut
ie
pbt
mening
respect
csf
total
ld
ck
activ
higher
mening
dog
dog
suppress
increas
activ
also
predomin
isoenzym
mening
dog
predomin
isoenzym
dog
ie
pbt
ld
ck
activ
canin
csf
may
use
diagnost
tool
distinguish
mening
neurolog
diseas
p
rc
da
sa
ac
td
veterinari
medicin
ohio
state
univers
columbu
heart
lung
research
institut
ohio
state
univers
medic
center
columbu
oh
purpos
studi
compar
cerebrospin
fluid
csf
cytokin
concentr
great
dane
gd
without
sign
cervic
spondylomyelopathi
csm
associ
cytokin
concentr
administr
diseas
sever
sever
spinal
cord
sc
compress
presenc
sc
signal
chang
gd
also
investig
thirti
gd
prospect
enrol
clinic
normal
dog
underw
mri
cervic
vertebr
column
cerebellomedullari
cistern
csf
collect
routin
csf
analysi
total
protein
cell
count
perform
commerci
avail
canin
multiplex
immunoassay
use
measur
concentr
granulocyt
macrophag
factor
induc
protein
cytokin
monocyt
chemoattract
tumor
necrosi
linear
regress
analysi
use
compar
cytokin
concentr
group
test
associ
use
sever
sign
sc
compress
sc
signal
chang
affect
gd
signific
differ
normal
affect
gd
routin
csf
analysi
concentr
gd
significantli
lower
concentr
normal
gd
p
moreov
affect
gd
sever
p
moder
p
sc
compress
mri
significantli
lower
concentr
mild
sc
compress
associ
cytokin
concentr
use
diseas
sever
affect
gd
concentr
significantli
higher
p
gd
sc
signal
chang
remaind
cytokin
detect
limit
lower
concentr
gd
might
interfer
monocyt
attract
slow
remov
myelin
debri
hinder
axon
regener
remyelin
markedli
higher
csf
concentr
gd
sc
signal
chang
suggest
sever
chronic
inflamm
subgroup
affect
gd
histopatholog
immunohistochem
studi
need
evalu
role
cytokin
csm
sa
av
rl
gr
js
state
univers
school
veterinari
medicin
pullman
state
univers
depart
crop
soil
scienc
pullman
wa
intervertebr
disc
diseas
common
chondrodystroph
dog
comput
tomographi
ct
magnet
reson
mr
imag
commonli
use
diagnos
extrud
intervertebr
disc
materi
eivdm
purpos
studi
evalu
accuraci
mr
ct
diagnos
eivdm
chondrodystroph
dog
thoracolumbar
disc
diseas
compar
intraop
find
chondrodystroph
dog
thoracolumbar
eivdm
underw
advanc
imag
surgeri
includ
studi
mr
ct
hemilaminectomi
surgeri
perform
dog
accuraci
ct
mr
locat
eivdm
identif
disc
herniat
occur
later
eivdm
distribut
respect
disc
space
spinal
cord
length
eivdm
compar
find
patient
temperatur
loss
durat
imag
procedur
also
compar
accuraci
site
eivdm
ct
mr
accuraci
disc
materi
later
modal
accuraci
eivdm
distribut
respect
disc
space
ct
mr
ct
mr
respect
spinal
cord
accuraci
data
compar
find
averag
ct
scan
took
minut
mr
minut
temperatur
loss
ct
mr
respect
imag
modal
compar
diagnosi
descript
thoracolumbar
eivdm
temperatur
loss
scan
durat
significantli
less
ct
compar
mr
j
delamaid
gasper
hl
barn
heller
l
trepani
robertson
univers
wisconsin
madison
wi
purpos
studi
determin
chronic
transderm
phenobarbit
pb
administr
achiev
serum
phenobarbit
concentr
ugml
healthi
cat
nineteen
healthi
staff
student
own
cat
divid
group
transderm
phenobarbit
pluron
lecithin
organogel
plo
group
group
appli
pinna
day
group
receiv
mgkg
q
hour
group
receiv
mgkg
q
hr
median
concentr
day
time
hour
post
drug
administr
ugml
ugml
ugml
ugml
group
ugml
ugml
ugml
ugml
group
ugml
ugml
ugml
ugml
group
one
cat
withdrawn
group
day
due
intoler
side
effect
addit
cat
ad
total
cat
complet
group
side
effect
mild
transient
cat
complet
studi
side
effect
includ
polyuria
polydipsia
polyphagia
sedat
ataxia
mild
paraparesi
pinna
erythema
increas
ear
groom
result
studi
show
therapeut
serum
phenobarbit
concentr
achiev
cat
follow
chronic
transderm
administr
pb
plo
pcca
lipoderm
mgkg
q
h
side
effect
minor
sr
e
c
l
de
veterinari
medicin
univers
georgia
usa
health
trust
newmarket
england
uk
veterinari
medicin
mississippi
state
univers
ideal
coma
score
system
scale
would
reliabl
valid
linear
easi
use
score
system
use
object
decid
proper
cours
treatment
monitor
success
therapi
provid
estim
prognosi
modifi
glasgow
coma
scale
mgc
develop
year
ago
guid
manag
assist
determin
prognosi
canin
felin
head
trauma
ht
although
valid
statist
relev
mgc
linear
alway
easi
use
entir
repres
clinic
present
seen
veterinari
medicin
address
concern
propos
amend
mgc
evalu
valid
prognost
valu
deriv
current
scale
aim
use
retrospect
valid
new
scale
determin
sampl
size
necessari
prospect
multicent
treatment
studi
mgc
amend
separ
score
system
maintain
subdivis
brainstem
reflex
motor
function
conscious
minim
scale
veterinari
cranial
injuri
score
vci
assign
subdivis
point
expans
scale
small
anim
coma
score
sac
total
point
low
score
indic
sever
dysfunct
retrospect
score
dog
present
one
three
referr
institut
subsequ
ht
outcom
scale
develop
base
assess
qualiti
life
qol
survivor
data
use
studi
obtain
medic
record
includ
neurolog
exam
heart
rate
temperatur
blood
chemistri
case
analys
perform
use
sa
v
test
signific
level
set
power
analys
perform
use
nqueri
dog
evalu
mean
mgc
score
mean
blood
glucos
valu
significantli
higher
dog
surviv
hour
signific
posit
correl
mgc
r
sac
r
vci
r
temperatur
r
heart
rate
r
qol
score
month
signific
posit
correl
mgc
r
sac
r
vci
r
temperatur
r
qol
score
month
mgc
present
score
posit
correl
sac
r
p
vci
r
p
score
sampl
size
calcul
prospect
treatment
studi
total
anim
sac
anim
vci
studi
valid
new
score
system
prognost
valu
dog
ht
new
clinic
outcom
score
use
assess
dog
month
trauma
term
qol
inform
deriv
studi
use
initi
prospect
treatment
trial
use
power
analysi
result
confirm
feasibl
sampl
size
rc
da
j
p
b
veterinari
clinic
scienc
ohio
state
univers
columbu
radiolog
ohio
state
univers
medic
center
columbu
oh
imag
scienc
school
medicin
vanderbilt
univers
nashvil
tn
cervic
spondylomyelopathi
csm
common
diseas
cervic
spine
larg
giant
breed
dog
limit
understand
diseas
mechan
lack
clearli
defin
outcom
measur
prognost
indic
despit
larg
varieti
surgic
techniqu
avail
treat
csm
surviv
affect
dog
need
improv
diffus
tensor
imag
dti
advanc
magnet
reson
imag
mri
techniqu
recent
appli
human
sensit
chang
tissu
microstructur
could
yield
prognost
inform
studi
aim
evalu
chang
fraction
anisotropi
fa
median
diffus
md
radial
diffus
rd
axial
diffus
ad
dog
without
csm
hypothes
dti
differ
would
exist
dog
compar
unaffect
dog
further
understand
diseas
mechan
fourteen
control
great
dane
enrol
analysi
novel
dti
protocol
optim
canin
cervic
vertebr
column
dog
underw
mri
protocol
imag
sagitt
transvers
plane
dti
protocol
consist
imag
repetit
time
tr
echo
time
te
ms
direct
slice
thick
mm
gap
use
proprietari
softwar
gener
tensor
estim
parametr
map
use
dti
studio
roi
editor
fa
md
rd
ad
measur
transvers
dti
slice
segment
disc
region
sagitt
transvers
weight
imag
dog
also
evalu
spinal
cord
signal
chang
linear
regress
analysi
demonstr
signific
differ
fa
rd
p
dog
without
csm
signific
differ
md
ad
p
dog
signific
differ
identifi
fa
rd
ad
compar
site
without
signal
chang
intervertebr
space
fa
rd
differ
suggest
demyelin
loss
axon
integr
present
spinal
cord
dog
evalu
spinal
cord
microstructur
dti
yield
inform
could
assist
treatment
prognost
dog
dolera
l
malfassi
la
cittadina
fondazion
studi
e
ricerch
veterinari
romanengo
cr
itali
atlantoaxi
instabl
surgic
condit
frequent
describ
toy
breed
dog
variou
correct
techniqu
describ
veterinari
literatur
aim
studi
describ
imag
find
novel
surgic
techniqu
stabilis
atlantoaxi
instabl
associ
incongru
atlantoaxi
joint
dog
five
dog
bodi
weight
kg
less
atlantoaxi
instabl
associ
articular
incongru
consid
clinic
examin
dog
show
tetraparesi
ataxia
ct
mri
articular
surfac
atla
larger
articular
surfac
axi
laxiti
atlantoaxi
ligament
evid
head
neck
flexion
axi
disloc
dorsal
cranial
spinal
canal
spinal
cord
show
chronic
compress
focal
hyperintens
seq
tse
variou
degre
syringomyelia
surgeri
anaesthetis
dog
posit
ventral
recumb
head
extend
neck
slight
linear
traction
appli
maxillari
canin
teeth
reduct
atlantoaxi
sublux
verifi
trough
fluoroscopi
standard
dorsal
approach
atla
axi
made
two
mm
self
tap
cortic
screw
insert
atla
wind
side
direct
three
mm
self
tap
cortic
screw
insert
transvers
dorsal
process
axi
screw
fuse
polymethylmethacryl
serial
clinic
imag
control
made
complic
observ
function
improv
occur
dog
serial
ct
examin
show
stabl
reduct
dorsal
cranial
axi
disloc
persist
residu
mild
spinal
compress
due
differ
size
articular
surfac
atla
axi
sever
mean
stabilis
atlantoaxi
disloc
describ
veterinari
literatur
standard
treatment
consist
ventral
arthrodesi
cross
pin
transarticular
lag
screw
fixat
vertebr
plate
techniqu
requir
atlantoaxi
joint
congruenc
otherwis
mean
synthesi
injur
spinal
cord
dorsal
techniqu
utilis
variou
sutur
materi
devic
kishigami
tension
band
howev
cranial
disloc
imping
axi
spinal
cord
adequ
counteract
techniqu
describ
simpl
safe
use
surgic
treatment
dog
atlantoaxi
disloc
articular
incongru
condit
resembl
atlantoaxi
invagin
describ
human
medicin
pf
rc
da
r
c
p
bay
area
veterinari
specialist
walnut
creek
northwest
veterinari
specialist
clackama
veterinari
clinic
scienc
ohio
state
univers
columbu
coast
veterinari
neurolog
neurosurgeri
houston
veterinari
specialti
group
chicago
specialti
care
mt
pleasant
sc
studi
evalu
limit
complic
cervic
disc
arthroplasti
cda
techniqu
use
adamo
spinal
dog
disc
associ
wobbler
syndrom
daw
consecut
dog
month
histori
daw
diagnos
mri
evalu
nineteen
dog
treat
singl
level
lesion
eleven
dog
two
level
lesion
three
dog
three
level
lesion
total
treat
disc
site
median
time
month
rang
week
month
time
write
dog
still
aliv
seven
dog
deceas
five
non
neurolog
diseas
one
dog
weigh
lb
euthan
week
compress
fractur
ventral
displac
implant
two
three
dog
present
month
tetraparesi
sever
extensor
rigid
front
leg
poor
outcom
one
dog
excess
bur
vertebr
end
plate
caus
immedi
subsid
two
dog
vertebr
fractur
fissur
occur
surgeri
distract
affect
clinic
outcom
site
subsid
observ
mostli
seen
narrow
andor
thicker
cranial
caudal
implant
use
subsid
except
one
dog
affect
clinic
outcom
correct
patient
select
dog
size
neurolog
statu
size
implant
endplat
prepar
appli
distract
surgeri
need
consid
import
factor
may
influenc
outcom
r
timothi
bentley
logan
sangster
ge
moor
purdu
univers
colleg
veterinari
medicin
west
lafayett
canin
pharamacoresist
epilepsi
common
pharmacoresist
dog
suffer
cluster
seizur
lead
increas
hospit
owner
frustrat
euthanasia
levetiracetam
propos
efficaci
given
intermitt
continu
crossov
pilot
studi
perform
six
dog
idiopath
epilepsi
continu
cluster
seizur
despit
receiv
two
mainten
drug
levetiracetam
therapeut
serum
concentr
dog
random
levetiracetam
period
month
follow
equal
length
placebo
period
receiv
mainten
throughout
levetiracetam
dose
mgkg
compound
capsul
placebo
capsul
ident
appear
owner
start
studi
drug
follow
seizur
owner
continu
give
studi
drug
everi
hour
dog
gone
hour
without
seizur
stop
next
seizur
dog
receiv
levetiracetam
puls
therapi
median
seizur
per
cluster
rang
compar
placebo
therapi
median
seizur
per
cluster
rang
p
dog
met
treatment
failur
criteria
placebo
period
n
levetiracetam
period
n
serum
concentr
phenobarbit
potassium
bromid
gener
lower
levetiracetam
period
placebo
period
although
statist
significantli
differ
p
levetiracetam
puls
therapi
cluster
seizur
begun
first
seizur
continu
hour
without
seizur
probabl
effect
idiopath
epilept
dog
warrant
investig
nj
eh
univers
ithaca
carolina
state
univers
raleigh
nc
dorsal
compress
lesion
atlantoaxi
junction
ie
dural
band
craniocerv
junction
anomali
frequent
seen
alongsid
craniocerv
junction
anomali
malform
despit
regular
identif
imag
clinic
signific
remain
unclear
address
author
investig
influenc
clinic
statu
syringomyelia
commonli
affect
breed
cavali
king
charl
spaniel
ckc
assess
neuropath
pain
neurolog
dysfunct
assign
neurolog
grade
magnet
reson
imag
craniocerv
junction
perform
head
neck
straight
flex
imag
studi
assess
dural
band
malform
cm
syringomyelia
dural
band
syringomyelia
sever
determin
use
compress
index
object
grade
subject
respect
ckc
imag
demonstr
neuropath
pain
dural
band
present
dog
cm
syringomyelia
found
dog
also
dural
band
dural
band
associ
presenc
sever
clinic
sign
presenc
syringomyelia
higher
compress
indic
associ
sever
syringomyelia
dural
band
appear
play
signific
clinic
role
compress
indic
provid
better
assess
dural
band
sever
compar
grade
p
k
k
k
forsberg
k
surgic
radiolog
scienc
school
veterinari
medicin
davi
anim
breed
genet
swedish
univers
agricultur
scienc
uppsala
immunolog
genet
patholog
uppsala
univers
pharmaceut
inc
novato
depart
medic
biochemistri
microbiolog
uppsala
univers
institut
harvard
massachusett
popul
health
reproduct
school
veterinari
medicin
davi
ca
glioma
devast
primari
brain
tumor
highli
overrepres
ancestr
breed
boxer
bulldog
boston
terrier
brachycephal
breed
pug
hypothes
associ
map
use
breed
would
identifi
genet
suscept
risk
factor
develop
glioma
associ
perform
primari
glioma
use
illumina
canin
snp
array
case
control
target
resequenc
control
glioma
sampl
perform
identifi
variant
glioma
associ
region
put
diseas
caus
mutat
western
blot
function
analys
perform
investig
candid
gene
signific
associ
identifi
cfa
appear
due
oligodendroglioma
case
across
breed
map
carri
signific
popul
stratif
magnitud
effect
associ
compel
bonferoni
p
x
haplotyp
identifi
homozyg
within
breed
high
preval
glioma
segreg
number
breed
three
candid
gene
identifi
document
interact
potenti
glioma
pathway
differenti
transcript
express
present
gene
compar
tumor
tissu
normal
brain
one
candid
gene
exon
singl
nucleotid
polymorph
result
decreas
gene
function
approxim
identifi
potenti
suscept
gene
glioma
may
provid
insight
gliomagenesi
well
provid
possibl
target
therapeut
breed
strategi
prevent
treatment
glioma
f
k
l
e
h
veterinari
colleg
guelph
ontario
program
unit
molecular
neurolog
depart
veterinari
bioscienc
univers
helsinki
research
center
helsinki
finland
canin
often
present
transient
paroxysm
event
hard
confirm
seizur
base
descript
observ
alon
electroencephalographi
eeg
correl
clinic
manifest
epileptiform
activ
allow
confirm
howev
sedat
gener
anesthesia
eeg
record
may
abolish
event
interest
retrospect
case
seri
describ
novel
canin
awak
ambulatori
wireless
video
eeg
techniqu
dog
investig
possibl
seizur
activ
select
eeg
case
record
techniqu
juli
march
result
case
subcutan
needl
wire
electrod
affix
scalp
sticki
bandag
sedat
requir
electrod
placement
either
dexmedetomidin
use
subsequ
revers
atipamezol
n
electrod
place
recoveri
gener
anesthesia
procedur
n
record
begin
recoveri
administr
sed
fourteen
electrod
place
per
dog
includ
ground
refer
imped
kept
kohm
ideal
kohm
possibl
replac
electrod
necessari
record
perform
use
lifelin
trackit
eeg
machin
review
use
persyst
softwar
record
length
rang
one
twelv
hour
one
dog
record
twice
two
separ
session
record
took
place
clinic
either
outpati
inpati
intens
care
unit
one
dog
addit
record
home
transient
paroxysm
event
investig
includ
seizur
n
alter
mentat
focal
twitch
n
n
head
bob
n
paroxysm
epileptiform
eeg
activ
confirm
three
dog
seizur
electr
seizur
accompani
visibl
motor
manifest
transient
paroxysm
episod
also
record
video
accompani
epileptiform
eeg
activ
n
dog
transient
episod
interest
occur
record
period
awak
ambulatori
wireless
video
eeg
help
diagnosi
case
similar
diagnost
yield
report
human
pediatr
eeg
techniqu
consid
canin
present
frequent
paroxysm
event
unknown
origin
kr
ja
mg
papich
north
carolina
state
univers
colleg
veterinari
medicin
raleigh
nc
levetiracetam
lev
common
antiepilept
medic
a
dog
refractori
seizur
concurr
phenobarbit
administr
alter
disposit
lev
healthi
dog
object
studi
evalu
pharmacokinet
lev
epilept
dog
administ
concurr
convent
a
eighteen
dog
mainten
therapi
lev
phenobarbit
pb
group
n
lev
bromid
br
group
n
lev
phenobarbit
bromid
group
n
enrol
a
attain
steadi
state
concentr
blood
sampl
collect
hour
morn
dose
lev
plasma
lev
concentr
determin
liquid
chromatographi
account
dose
differ
among
dog
lev
concentr
normal
mean
studi
dose
mgkg
pharmacokinet
analysi
perform
adjust
concentr
use
noncompartment
method
auc
calcul
use
trapezoid
method
compar
pb
group
br
group
significantli
higher
cmax
versu
respect
h
versu
h
h
respect
significantli
lower
clf
mlhkg
versu
mlhkg
mlhkg
respect
concurr
administr
phenobarbit
alon
combin
bromid
significantli
alter
disposit
lev
epilept
dog
compar
concurr
administr
bromid
alon
find
warrant
consider
util
lev
therapi
dog
epilepsi
j
j
ms
bdx
pain
research
laboratori
north
carolina
state
univers
colleg
veterinari
medicin
raleigh
genom
laboratori
north
carolina
state
univers
depart
anim
scienc
raleigh
nc
degen
joint
diseas
djd
clinic
relev
common
condit
affect
domest
cat
speci
includ
human
identif
neurobiolog
signatur
pain
well
develop
pain
model
rodent
howev
inform
lack
anim
human
natur
occur
pain
condit
studi
identif
housekeep
gene
hkg
neuron
tissu
express
level
gene
consid
associ
chronic
pain
rodent
model
explor
cat
natur
occur
osteoarthrit
pain
eighteen
adult
cat
evalu
normal
hind
limb
radiograph
djd
express
pain
signal
gene
includ
ngf
trka
lumbar
spinal
cord
dorsal
horn
lumbar
dorsal
root
ganglia
joint
capsul
tissu
normal
studi
use
quantit
qpcr
hkg
identifi
stabl
across
tissu
sampl
mani
ribosom
protein
gene
qpcr
result
show
downregul
ngf
upregul
gene
spinal
cord
downregul
dorsal
root
ganglia
collect
gene
differenti
express
joint
capsul
sampl
due
high
level
variabl
healthi
sampl
sever
gene
expect
upregul
base
result
rodent
model
downregul
work
need
understand
neurobiolog
pain
natur
occur
diseas
rodent
model
predict
chang
natur
occur
clinic
pain
condit
ac
sr
cg
hadjipanayi
anim
health
trust
newmarket
veterinari
medicin
univers
georgia
athen
univers
school
medicin
winship
cancer
institut
emori
univers
atlanta
ga
convect
enhanc
deliveri
ced
allow
target
treatment
intracrani
neoplasia
overcom
restrict
blood
brain
barrier
aim
studi
evalu
safeti
efficaci
ced
cetuximab
antibodi
epiderm
growth
factor
receptor
egfr
adjunct
treatment
intracrani
glioma
dog
nine
dog
intracrani
glioma
includ
dog
underw
surgic
debulk
tumor
intraop
histopatholog
confirm
two
ced
cathet
place
within
tumor
caviti
attach
medtron
titanium
synchronom
ii
pump
contain
bioconjug
oxid
nanoparticl
ionp
pump
secur
head
bodi
dog
recoveri
set
infus
hour
dog
includ
boxer
boston
terrier
one
pit
bull
one
french
bulldog
one
english
bulldog
mix
breed
clinic
sign
includ
seizur
circl
mentat
chang
tumor
supratentori
oligodendroglioma
astrocytoma
mri
perform
follow
time
point
patient
aliv
hour
day
week
month
year
year
side
effect
drug
deliveri
note
mri
hour
confirm
cathet
placement
ionp
presenc
tumor
bed
case
time
write
dog
still
aliv
five
dog
euthan
recurr
neurolog
sign
circl
mentat
chang
seizur
median
surviv
time
mst
surgeri
group
patient
euthan
month
mean
month
rang
month
current
median
surviv
time
dog
still
aliv
month
mean
month
rang
month
overal
mst
includ
surviv
euthan
patient
month
mean
month
rang
month
ced
cetuximab
safe
practic
adjunct
treatment
surgic
debulk
canin
patient
intracrani
glioma
base
pilot
studi
ced
bioconjug
may
effect
treatment
canin
intracrani
glioma
ced
infus
perform
consciou
patient
durat
shown
experiment
improv
volum
diffus
within
target
tissu
ultim
larger
placebo
control
blind
clinic
trial
necessari
underway
understand
role
treatment
canin
intracrani
glioma
dg
j
nk
c
di
jh
mp
bt
nation
univers
colleg
veterinari
medicin
cheongju
south
basic
scienc
institut
ochang
south
nation
univers
colleg
veterinari
medicin
jinju
south
korea
intracerebr
hemorrhag
ich
one
lethal
stroke
type
neuroimag
techniqu
particularli
comput
tomographi
magnet
reson
imag
mri
improv
accuraci
diagnosi
intracerebr
hemorrhag
human
mr
featur
five
distinct
stage
ich
alreadi
report
object
verifi
dog
therefor
purpos
investig
document
sequenti
mr
characterist
canin
ich
accord
evolv
stage
ich
induc
healthi
laboratori
beagl
dog
inject
u
bacteri
collagenas
clostridium
histolyticum
deliv
pariet
lobe
min
micro
infus
pump
imag
dwi
measur
appar
diffus
coeffici
adc
gre
imag
perform
serial
differ
time
point
use
mr
system
h
day
ich
mr
featur
experi
summar
tabl
result
differ
previou
report
human
individu
time
variat
may
vari
mr
find
present
data
could
use
differenti
clinic
stage
ich
canin
patient
j
mn
toulous
inp
nation
veterinari
school
toulous
toulous
nant
franc
ataxia
observ
litter
belgian
shepherd
phenotyp
normal
parent
four
puppi
litter
display
ident
clinic
sign
affect
puppi
grew
well
began
walk
normal
week
demonstr
worsen
ambulatori
difficulti
three
puppi
present
teach
hospit
evalu
gener
physic
examin
normal
neurolog
examin
reveal
sever
ataxia
presum
cerebellar
origin
hypermetr
ataxia
intent
tremor
delay
propriocept
limb
menac
respons
spinal
reflex
normal
litterm
affect
unabl
walk
result
complet
biochem
hematolog
examin
perform
one
present
puppi
within
laboratori
refer
interv
except
mild
hypomagnesemia
cerebrospin
fluid
analysi
dog
normal
pcr
analysi
neg
distemp
toxoplasma
neospora
parvoviru
magnet
reson
imag
brain
perform
affect
puppi
normal
femal
litter
normal
femal
compat
congenit
cerebellar
abiotrophi
affect
puppi
present
puppi
euthan
similar
histopatholog
lesion
found
suggest
cerebellar
abiotrophi
loss
purkinj
granul
cell
author
knowledg
affect
describ
breed
lim
nj
olbi
north
carolina
state
univers
colleg
veterinari
medicin
raleigh
nc
therapeut
strategi
develop
neurolog
disord
schwann
cell
sc
support
axon
regener
remyelin
advantag
easili
retriev
patient
allow
transplant
autolog
popul
cell
import
consider
sc
prepar
reduc
contamin
fibroblast
obtain
larg
number
cell
short
period
avoid
detriment
consequ
patient
harvest
report
obtain
nerv
biopsi
dorsal
cervic
cutan
region
purifi
expand
sc
harvest
small
piec
dorsal
cutan
cervic
nerv
dog
predegener
tissu
cultur
condit
enhanc
sc
growth
reduc
number
undesir
fibroblast
cell
immunopurifi
use
magnet
bead
puriti
evalu
assess
express
cell
surfac
antigen
half
million
cell
gener
day
less
mg
wet
weight
singl
nerv
fascicl
purif
process
cultur
contain
sc
howev
prolong
time
purif
indic
sc
abil
prolifer
decreas
conclud
biopsi
dorsal
cervic
cutan
nerv
safe
practic
cultur
protocol
yield
suffici
autolog
sc
popul
clinic
use
gd
c
j
k
la
california
san
diego
la
jolla
univers
clemson
univers
colleg
station
minnesota
st
paul
mn
congenit
myasthen
syndrom
heterogen
disord
associ
mutat
protein
resid
nerv
termin
synapt
basal
lamina
region
motor
endplat
result
compromis
safeti
margin
neuromuscular
transmiss
congenit
myasthenia
gravi
cmg
describ
clinic
dog
breed
includ
jack
russel
terrier
smooth
fox
terrier
dachshund
old
danish
point
dog
recent
identifi
labrador
retriev
date
character
cmg
molecular
level
perform
old
danish
point
dog
mutat
chat
gene
purpos
work
identifi
genet
basi
cmg
famili
labrador
retriev
caus
mutat
human
cmg
identifi
gene
reduc
list
candid
gene
illumina
canin
hd
infinum
beadchip
use
gener
snp
profil
nuclear
famili
compris
sire
dam
affect
puppi
unaffect
litterm
genotyp
analyz
genom
inherit
pattern
chromosom
segment
consist
autosom
recess
mode
inherit
ie
heterozygos
parent
homozygos
affect
puppi
allel
absent
heterozyg
litterm
identifi
region
harbor
candid
gene
chrnd
chrng
colq
sequenc
repres
code
region
gene
affect
puppi
carrier
sire
unrel
labrador
retriev
reveal
missens
mutat
colq
alter
conserv
residu
evalu
mutat
extend
famili
member
identifi
carrier
found
unrel
labrador
retriev
data
suggest
colq
mutat
caus
cmg
labrador
retriev
proper
use
genet
test
prevent
widespread
transmiss
popular
breed
bk
sturg
p
marco
er
wisner
pf
moor
rj
higgin
school
veterinari
medicin
univers
california
davi
davi
ca
canin
lymphoma
compris
hematopoiet
tumor
caus
intracrani
lesion
central
nervou
system
cn
cn
lesion
secondari
metastas
part
wide
dissemin
diseas
organ
contrast
defin
primari
cn
lesion
base
exclus
extraneur
involv
howev
studi
relationship
magnet
reson
imag
mri
profil
histolog
phenotyp
anatom
base
pattern
either
primari
secondari
cn
lymphoma
studi
lymphoma
case
rigor
necropsi
examin
classifi
secondari
cn
tumor
immunophenotyp
relev
canin
specif
cell
marker
antigen
identifi
granzym
b
lymphoma
one
suspect
cell
origin
seven
main
histolog
type
follow
current
accept
criteria
diffus
larg
n
peripher
n
lymphoma
major
one
identifi
type
reveal
lesion
distinct
signatur
anatom
pattern
compris
combin
parenchym
mening
choroid
plexu
subventricular
perivascular
spinal
cranial
spinal
nerv
involv
addit
profil
type
correl
mri
chang
tumor
dissemin
distribut
spinal
cord
orand
brain
remaind
restrict
either
supratentori
infratentori
site
pituitari
gland
involv
case
irrespect
phenotyp
except
absenc
larg
granular
lymphoma
type
jh
r
r
cs
r
se
state
univers
flint
anim
cancer
center
fort
collin
market
commun
inc
fort
collin
research
loveland
co
clinic
trial
use
veterinari
medicin
assess
util
efficaci
new
treatment
protocol
surgic
intervent
diagnost
techniqu
rate
enrol
clinic
trial
wide
unknown
like
vari
institut
assum
element
clinic
research
may
prevent
enrol
elig
patient
clinic
trial
possibl
barrier
patient
enrol
distanc
clinic
invas
procedur
risk
unknown
side
effect
postul
factor
may
decreas
clinic
trial
particip
systemat
evalu
veterinari
medicin
date
purpos
studi
identifi
pet
owner
perceiv
barrier
benefit
particip
veterinari
oncolog
clinic
trial
client
flint
anim
cancer
center
facc
colorado
state
univers
survey
evalu
barrier
clinic
trial
particip
motiv
would
increas
particip
factor
might
influenc
client
process
regard
enrol
second
popul
pet
owner
client
facc
denver
metro
area
survey
evalu
similar
criteria
survey
complet
facc
client
pet
owner
major
facc
client
report
distanc
clinic
barrier
clinic
trial
particip
will
drive
mile
distinct
client
alreadi
travel
facc
pet
owner
denver
region
unwil
drive
greater
mile
particip
trial
percent
facc
client
indic
refer
facc
primari
care
veterinarian
pet
owner
report
primari
care
veterinarian
main
resourc
cancer
treatment
recommend
referr
reput
trial
center
referr
primari
care
veterinarian
ultim
influenti
factor
trial
particip
cost
servic
risk
side
effect
distanc
clinic
trial
center
group
facc
client
pet
owner
like
particip
clinic
trial
knew
research
would
benefit
anim
possibl
peopl
might
benefit
result
veterinari
clinic
trial
influenti
veterinari
clinic
trial
recruit
focu
outreach
commun
primari
care
veterinarian
avail
trial
well
inform
regard
benefit
risk
made
readili
access
easi
use
veterinarian
commun
pet
owner
emphas
benefit
clinic
trial
specif
anim
health
order
encourag
clinic
trial
particip
r
j
g
hs
l
k
van
de
h
de
univers
faculti
veterinari
medicin
merelbek
univers
faculti
veterinari
medicin
utrecht
netherland
goal
research
investig
presenc
mutat
differ
rel
express
candid
gene
explor
new
therapeut
target
investig
clinic
patholog
immunohistochem
prognost
marker
canin
thyroid
cancer
medic
record
ghent
utrecht
univers
review
dog
diagnos
histolog
confirm
thyroid
neoplasia
includ
tumor
section
n
review
score
pathologist
histolog
type
necrosi
hemorrhag
nuclear
pleomorph
mitot
index
evid
vascular
capsular
invas
immunohistochemistri
perform
calcitonin
vegf
differenti
follicular
cell
tumor
medullari
tumor
base
immunohistochemistri
calcitonin
rna
isol
tumor
sampl
n
healthi
thyroid
n
sequenc
perform
mutat
hotspot
ra
k
h
n
ret
braf
gene
complet
code
region
pten
quantit
perform
egfr
pten
calcitonin
tumor
carcinoma
follicular
thyroid
carcinoma
ftc
medullari
thyroid
carcinoma
mtc
ftc
mtc
missens
mutat
respect
found
rel
express
egfr
gene
significantli
higher
ftc
mtc
healthi
control
ftc
mtc
exhibit
high
percentag
neoplast
cell
immunoposit
vegf
ftc
mtc
present
express
ftc
mtc
present
express
tumor
immunoposit
dog
ftc
mtc
stage
underw
thyroidectomi
includ
surviv
analysi
outcom
compar
ftc
mtc
inappet
p
histolog
vascular
invas
p
surgic
vascular
invas
p
associ
shorter
surviv
histolog
vascular
invas
p
larg
tumor
diamet
p
high
label
index
p
associ
shorter
time
metastas
rel
express
candid
gene
suggest
pathway
activ
ftc
mtc
vegf
potenti
therapeut
target
ftc
mtc
seem
attract
molecular
target
canin
mtc
intens
monitor
adjunct
therapi
might
indic
neg
prognost
factor
identifi
l
malfassi
dolera
la
cittadina
fondazion
studi
e
ricerch
veterinari
romanengo
cr
itali
stereotact
radiosurgeri
sr
hypofraction
stereotact
radiotherapi
hsrt
advanc
method
treatment
tumour
usual
perform
head
frame
purpos
studi
evalu
feasibl
efficaci
frameless
linac
base
sr
hsrt
brain
spinal
neoplast
diseas
dog
cat
anim
dog
cat
presumpt
case
histolog
confirm
case
cancer
nervou
system
consid
case
rt
cur
adjuv
patient
receiv
diagnost
high
field
mri
simul
ct
expans
gtv
ptv
plan
treatment
volum
mm
direct
feasibl
frameless
sr
hsrt
studi
use
montecarlo
statist
algorith
cm
monaco
treatment
plan
system
tp
linac
mv
beam
modul
assess
treatment
feasibl
treatment
simul
perform
air
dosimetr
check
softwar
use
iview
portal
asi
imag
anim
place
stereotact
cradl
posit
verif
perform
cone
beam
ct
control
perform
serial
clinic
mri
examin
patient
meningioma
glioma
nerv
sheath
tumour
pituitari
tumour
pineal
tumour
complet
therapi
dose
deliv
rang
gy
fraction
gy
fraction
prescrib
isodos
rtog
toxic
show
month
recist
efficaci
show
partial
respons
stabl
diseas
complet
respons
diseas
progress
overal
respons
rate
either
stabl
diseas
patient
show
clinic
improv
case
control
diseas
clinic
improv
obtain
toxic
effect
quit
content
short
medium
term
efficaci
compar
superior
obtain
fraction
schedul
sr
hsrt
safe
effect
control
nervou
system
tumour
dog
cat
rj
milner
n
chimura
salut
univers
florida
colleg
veterinari
medicin
gainesvil
fl
research
report
provid
background
research
inform
target
gangliosid
tumor
antigen
provid
result
prospect
studi
previous
show
disialogangliosid
found
high
concentr
surfac
canin
melanoma
cell
lower
concentr
osteosarcoma
cell
combin
adjuv
vaccin
abl
elicit
humor
cytotox
cellular
immun
respons
normal
dog
report
result
prospect
iacuc
approv
clinic
trial
dog
melanoma
n
dog
enter
receiv
vaccin
accrual
includ
oral
cutan
pedal
nodal
anal
melanoma
melanoma
grade
low
n
intermedi
n
high
grade
n
immun
respons
monitor
use
cytokin
assay
antibodi
cytotox
assay
side
effect
found
use
cbc
chemistri
ua
inject
site
respons
singl
dog
show
allerg
reaction
local
swell
multivari
analysi
found
anatom
site
histolog
grade
univari
analysi
found
igg
titer
prevaccin
nk
assay
tumor
stage
influenc
surviv
paradox
case
decreas
igg
titer
prolong
surviv
compar
increas
stabl
titer
serum
endogen
concentr
determin
dog
melanoma
melanoma
case
higher
level
serum
case
accrual
continu
studi
equin
melanoma
studi
c
weiss
berent
anim
medic
center
new
york
ny
canin
urotheli
carcinoma
remain
diseas
poor
clinic
respons
therapi
initi
biolog
respons
patient
death
typic
occur
within
year
follow
diagnosi
contrari
theoret
advantag
radic
surgic
resect
rerout
procedur
provid
prolong
surviv
time
report
complic
may
dissuad
owner
procedur
hypothes
radic
cystectomi
sub
placement
would
permit
aggress
wider
tumor
resect
associ
complic
three
dog
extens
bladder
tcc
bilater
ureter
obstruct
incontin
includ
common
comorbid
includ
sever
azotemia
previou
therapi
includ
previou
surgic
resect
chemotherapi
among
other
dog
receiv
total
cystectomi
bilater
partial
ureterectomi
partial
urethrectomi
placement
bilater
sub
devic
norfolk
vet
major
complic
encount
surgic
time
rang
minut
complic
includ
urinari
tract
infect
kink
urethr
cathet
requir
extens
ad
subcutan
port
biopsi
tumor
cell
present
urethr
surgic
margin
two
dog
ultim
die
euthan
progress
azotemia
day
transfus
reaction
azotemia
day
one
dog
remain
aliv
day
sub
devic
flush
confirm
patenc
three
dog
dog
identifi
local
tumor
recurr
total
cystectomi
sub
placement
potenti
option
dog
extens
tcc
order
achiev
wide
tumor
excis
larg
excis
necessari
achiev
complet
margin
jn
sm
k
l
k
bk
b
b
cj
c
ka
missouri
columbia
state
univers
pullman
washington
seattl
wa
artemisinin
describ
properti
artemisinin
vegf
survivin
cancer
cell
caus
apoptot
death
artesun
deriv
better
oral
absorpt
dog
artemisinin
hypothesi
oral
artesun
toler
doxorubicin
result
longer
interv
dfi
doxorubicin
placebo
dog
stage
lymphoma
qualifi
dog
random
blind
receiv
artesun
mgkg
equival
placebo
dog
receiv
studi
drug
alon
hour
receiv
mgkg
doxorubicin
week
three
dose
studi
drug
thereaft
lymph
node
measur
cbc
chemistri
profil
urinalysi
monitor
monthli
diseas
progress
differ
dfi
compar
test
signific
set
p
artesun
alon
caus
clinic
remiss
p
artesun
induc
biochem
toxicosi
one
dog
experienc
progress
diseas
follow
doxorubicin
other
experienc
complet
respons
artesun
caus
greater
neutropenia
thrombocytopenia
follow
doxorubicin
p
p
dfi
differ
group
placebo
artesun
p
dog
receiv
artesun
higher
nucleat
red
blood
cell
count
median
artesun
placebo
p
red
cell
display
poikilocytosi
basophil
stippl
dog
artesun
caus
remiss
singl
agent
improv
dfi
dog
treat
doxorubicin
mgkg
artesun
caus
evid
heme
stress
treat
dog
artesun
otherwis
well
toler
doxorubicin
artesun
recommend
therapi
lymphoma
dog
ak
g
cj
kw
sj
tennesse
colleg
veterinari
medicin
knoxvil
clinic
colleg
medicin
rochest
mn
oncolyt
virotherapi
emerg
approach
cancer
therapi
wherein
natur
oncolyt
virus
mediat
tumor
destruct
elicit
secondari
immun
respons
novel
recombin
oncolyt
viru
document
efficaci
safeti
preclin
murin
model
cancer
safeti
studi
normal
dog
determin
safe
dose
viru
clinic
studi
dog
seven
dog
measur
malign
enrol
ongo
clinic
trial
either
vsv
express
either
human
n
canin
n
sodium
iodid
symport
ni
varieti
malign
repres
includ
lymphoma
malign
melanoma
multipl
myeloma
two
dog
demonstr
partial
respons
singl
iv
dose
viru
last
day
respect
dog
receiv
vsv
express
human
cell
lymphoma
treat
dog
achiev
either
stabl
n
progress
n
diseas
day
studi
period
clinic
toxic
develop
within
first
day
viral
administr
dog
includ
mild
moder
acut
hepat
enzymopathi
fever
urinari
tract
infect
dog
develop
neutral
antibodi
within
day
viral
administr
appear
shed
infecti
viru
urin
saliva
infecti
viru
isol
pbmc
one
dog
day
viru
administr
within
first
hour
follow
system
vsv
administr
overal
result
demonstr
measur
respons
oncolyt
vsv
observ
dog
cancer
start
dose
appear
may
allow
dose
escal
andor
repeat
dose
viru
addit
studi
underway
determin
prognost
factor
respons
therapi
wider
knowledg
respons
rate
dog
hematolog
solid
malign
lc
ke
v
tj
medic
comprehens
cancer
center
clinic
translat
research
univers
madison
wi
wnt
signal
pathway
aid
regul
cell
prolifer
differenti
migrat
aberr
activ
implic
tumor
develop
cell
cell
abil
divid
asymmetr
either
addit
cell
progeni
perform
microarray
analysi
compar
six
canin
primari
osteosarcoma
cell
line
identifi
gene
n
tumorigen
n
cell
line
among
gene
express
increas
greatest
extent
fold
tumorigen
cell
line
compar
cell
line
wnt
ligand
associ
inhibit
signal
aggress
tumor
qpcr
western
blot
analys
confirm
increas
express
tumorigen
cell
line
addit
tumorigen
cell
line
associ
increas
percentag
side
popul
cell
compar
cell
line
versu
respect
addit
studi
necessari
confirm
conceiv
increas
express
express
may
inhibit
canon
wnt
signal
pathway
therebi
contribut
format
cell
newli
gener
canin
primari
osteosarcoma
cell
line
benefici
address
import
question
ld
garrett
le
selmic
rl
kamer
tm
fan
univers
illinoi
depart
veterinari
medicin
il
purpos
investig
character
clinic
effect
bone
biolog
activ
biomechan
effect
acceler
radiat
protocol
adjuv
zoledron
manag
canin
appendicular
osteosarcoma
os
pain
prospect
dog
os
treat
ioniz
radiat
gray
x
day
intraven
zoledron
mgkg
day
everi
day
oral
analges
continu
everi
day
client
complet
pain
score
assess
form
object
data
includ
bone
biolog
effect
urin
ntx
dexa
biomechan
limb
function
computer
gait
analysi
videotap
assess
obtain
thorac
limb
radiograph
perform
initi
month
regular
interv
palli
protocol
well
toler
document
unaccept
radiat
side
effect
toxic
associ
zoledron
administr
fifti
dog
fail
median
day
ci
failur
fail
due
local
diseas
fail
due
metastasi
fail
due
caus
median
time
failur
local
diseas
day
ci
median
time
failur
metastasi
day
ci
differ
approach
signific
p
median
surviv
time
dog
day
ci
univari
analysi
elev
alp
diagnosi
tumor
locat
found
prognost
time
failur
surviv
dog
achiev
pain
control
greater
month
uniformli
demonstr
posit
chang
bone
biolog
effect
biomechan
limb
function
find
prospect
clinic
trial
suggest
acceler
radiat
zoledron
oral
analges
well
toler
provid
pain
allevi
exert
posit
bone
biolog
biomechan
effect
dog
os
k
veterinari
clinic
scienc
patholog
pathogen
biolog
royal
veterinari
colleg
rvc
london
uk
inflammasom
intracellular
complex
coordin
matur
interleukin
il
respons
pathogen
metabol
danger
signal
recent
research
shown
imbal
mrna
express
sever
signal
protein
inflammasom
pathway
dog
chronic
enteropathi
howev
protein
express
assess
far
studi
investig
express
duoden
mucosa
dog
chronic
enteropathi
frd
treatment
healthi
dog
use
immunohistochemistri
nine
dog
frd
includ
studi
treat
hydrolys
diet
week
biopsi
dog
avail
treatment
clinic
score
ccecai
allenspach
obtain
treatment
duoden
biopsi
healthi
beagl
use
control
immunohistochemistri
perform
use
polyclon
rabbit
primari
antibodi
dilut
abcam
cambridg
uk
follow
peroxidas
polym
detect
kit
suppli
vectorlab
slide
view
magnif
use
olympu
microscop
cell
count
randomli
select
villou
region
region
lamina
propria
lp
express
posit
cell
per
high
power
field
hpf
total
count
produc
cell
increas
frd
dog
compar
control
decreas
treatment
elimin
diet
median
number
posit
cellshpf
healthi
dog
rang
frd
treatment
rang
frd
treatment
rang
kruskal
walli
p
pair
test
frd
vs
treatment
p
interestingli
reflect
quantit
chang
protein
produc
cell
villi
median
number
posit
cellshpf
healthi
dog
rang
frd
treatment
rang
frd
treatment
rang
kruskal
walli
p
mostli
caus
increas
posit
cell
lp
entir
return
baselin
valu
treatment
median
number
posit
cellshpf
healthi
dog
rang
frd
treatment
rang
frd
treatment
rang
kruskal
walli
p
unpair
test
healthi
vs
frd
p
pair
test
frd
vs
treatment
p
decreas
posit
cell
lp
correl
ccecai
spearman
rank
conclus
studi
indic
protein
express
increas
dog
frd
compar
healthi
dog
decreas
treatment
correl
ccecai
js
ml
c
e
jm
sl
laboratori
texa
univers
colleg
station
tx
refer
laboratori
west
sacramento
ca
loomi
basin
veterinari
clinic
loomi
ca
veterinari
medicin
univers
california
davi
ca
recent
molecular
studi
reveal
highli
complex
bacteri
microbiota
intestin
cat
mount
evid
microb
play
import
role
pathogenesi
acut
chronic
gastrointestin
gi
diseas
composit
chang
intestin
bacteri
ecosystem
associ
intestin
inflamm
human
dog
aim
studi
evalu
fecal
microbiom
cat
diarrhea
fecal
sampl
obtain
healthi
cat
n
cat
diarrhea
n
diseas
cat
compar
base
durat
diarrhea
durat
day
n
vs
durat
day
n
bacteri
composit
analyz
next
gener
sequenc
rrna
use
platform
life
technolog
depth
sequenc
read
per
sampl
rrna
gene
sequenc
also
use
input
bioinformat
softwar
picrust
predict
function
gene
content
microbiom
diseas
group
linear
discrimin
analysi
lda
effect
size
lefs
perform
identifi
bacteri
group
significantli
associ
diseas
durat
differ
bacteri
group
predict
gene
content
group
analyz
use
test
test
result
correct
multipl
comparison
use
benjamini
hochberg
fals
discoveri
rate
adjust
p
signific
differ
bacteri
group
detect
healthi
cat
cat
diarrhea
base
lda
enterobacteriacea
streptococcu
burkholderial
collinsella
significantli
increas
diarrheic
cat
megamona
bacteroidet
helicobact
campylobacteral
roseburia
significantli
increas
healthi
cat
signific
differ
abund
specif
bacteri
group
also
observ
cat
base
durat
diarrhea
bacteroidet
significantli
decreas
cat
diarrhea
day
lactobacillu
erysipelotrichi
significantli
decreas
cat
diarrhea
day
observ
chang
bacteri
group
accompani
signific
differ
function
gene
content
metabol
fatti
acid
biosynthesi
glycosphingolipid
metabol
biotin
metabol
tryptophan
ascorb
aldar
metabol
significantli
p
alter
cat
diarrhea
conclus
mention
molecular
approach
reveal
signific
differ
fecal
microbiom
healthi
cat
cat
diarrhea
dysbiosi
accompani
chang
bacteri
function
gene
categori
futur
studi
warrant
evalu
microbi
chang
correl
chang
fecal
concentr
microbi
metabolit
cat
diarrhea
identif
potenti
diagnost
therapeut
target
sturgeon
cm
jardin
js
wees
univers
guelph
guelph
canada
domest
dog
cani
familiari
evolv
grey
wolf
cani
lupu
approxim
year
ago
evid
diverg
evolut
gene
respons
digest
individu
consid
optim
diet
pet
dog
evolutionarili
appropri
diet
similar
use
wild
wolv
emphasi
raw
meat
feed
genom
wolv
dog
compar
intestin
microbiota
wild
wolv
dog
compar
limit
evalu
differ
intestin
microbiota
dog
fed
convent
diet
raw
meat
diet
object
studi
compar
fecal
microbiota
wild
wolv
dog
fed
convent
dri
diet
dc
dog
fed
raw
meat
diet
dr
fecal
sampl
collect
fifteen
pet
dog
dc
dr
ten
wild
wolv
ww
next
gener
sequenc
rrna
gene
region
pcr
product
perform
data
analys
use
mothur
sequenc
pass
qualiti
control
filter
cluster
oper
taxon
unit
otu
singleton
doubleton
repres
otu
sequenc
subsampl
read
comparison
dog
group
dc
dr
wolv
ww
read
comparison
dc
dr
pcoa
plot
phylogenet
tree
base
jaccard
index
demonstr
clear
differ
wolv
dog
someth
support
analysi
molecular
varianc
amova
contrast
differ
microbi
popul
membership
structur
dc
dr
group
speci
rich
estim
use
catchal
dog
wolv
preval
phyla
wolf
scat
firmicut
sequenc
proteobacteria
actinobacteria
verrucomicrobia
fusobacteria
unclassifi
bacteria
repres
sequenc
four
wolv
almost
complet
compris
firmicut
proteobacteria
domin
six
phylum
level
distribut
similar
dog
main
phyla
firmicut
sequenc
verrucomicrobia
spirochaet
fibrobacter
proteobacteria
bacteroidet
tenericut
fusobacteria
contrast
wolv
unclassifi
bacteria
repres
sequenc
dog
sampl
fecal
microbiota
wolv
highli
variabl
perhap
reflect
variabl
inconsist
diet
wild
canid
contrast
fecal
microbiota
dog
conserv
differ
popul
structur
dog
diet
impact
fecal
microbiota
individu
dog
fecal
microbi
popul
membership
structur
rel
conserv
amongst
differ
feed
group
feed
dog
raw
meat
result
develop
fecal
microbiota
akin
wolv
reynold
e
satyaraj
nestl
purina
research
st
loui
mo
spirulina
refer
two
speci
blue
green
alga
arthrospira
platensi
maxima
consum
human
food
centuri
spirulina
shown
immun
enhanc
properti
anim
human
studi
attribut
polysaccharid
act
via
process
howev
systemat
studi
evalu
immunomodulatori
effect
spirulina
dog
aim
studi
evalu
immunomodulatori
effect
diet
supplement
spirulina
dog
studi
conduct
two
phase
wk
test
wk
dog
mean
yr
random
two
group
phase
group
fed
nutrit
complet
diet
end
phase
dog
receiv
rabi
vaccin
dog
test
group
switch
nutrit
complet
diet
supplement
dri
arthrospira
platensi
spirulina
respons
rabi
vaccin
evalu
rapid
flouresc
focu
inhibit
test
rffit
gut
immun
respons
assess
measur
fecal
iga
gut
microflora
evalu
tempor
temperatur
gel
electrophoresi
ttge
methodolog
repeat
measur
analysi
varianc
use
test
differ
group
statist
signific
consid
p
dog
fed
diet
supplement
spirulina
demonstr
enhanc
immun
statu
show
significantli
higher
vaccin
respons
higher
level
fecal
iga
compar
control
group
supplement
diet
spirulina
also
result
significantli
increas
gut
microflora
stabil
test
group
conclus
diet
supplement
spirulina
significantli
enhanc
immun
health
gut
health
dog
e
de
r
hospit
univers
pennsylvania
philadelphia
vista
anim
hospit
ottawa
veterinari
specialist
greenvil
sc
purpos
studi
evalu
safeti
efficaci
satisfact
associ
novel
variabl
diamet
tracheal
stent
design
specif
canin
anatomi
tracheal
collaps
multicent
retrospect
studi
consecut
case
tracheal
collaps
treat
stent
data
form
requir
chart
review
client
interview
distribut
veterinarian
place
stent
inform
collect
compar
symptom
well
number
paramet
relat
procedur
subsequ
clinic
cours
assess
stent
perform
eas
use
symptom
grade
visual
line
scale
pair
sign
rank
test
use
determin
chang
symptom
follow
stent
consid
statist
signific
respons
obtain
case
data
normal
distribut
mean
durat
month
rang
month
procedur
complic
oper
mortal
stent
fractur
stent
relat
death
symptomat
granul
tissu
develop
one
case
statist
signific
improv
seen
cough
respiratori
function
qualiti
life
exercis
toler
veterinarian
state
would
use
stent
client
would
repeat
procedur
express
satisfact
outcom
tracheal
stent
perform
novel
implant
safe
subject
effect
significantli
improv
clinic
symptom
veterinarian
client
express
posit
percept
regard
outcom
associ
stent
ba
scansen
depart
veterinari
clinic
scienc
ohio
state
univers
columbu
oh
implant
size
tracheal
stent
convent
select
fluoroscop
measur
maxim
dorsoventr
tracheal
diamet
aim
studi
determin
tracheal
ct
dimens
compar
fluoroscopi
also
evalu
chang
tracheal
cross
section
area
csa
posit
pressur
ventil
apnea
twelv
dog
tracheal
collaps
requir
stent
implant
prospect
enrol
comput
tomographi
fluoroscopi
perform
posit
pressur
apnea
endotrach
tube
beyond
larynx
tracheal
diamet
measur
later
ct
dorsoventr
ct
fluoroscopi
plane
tracheal
csa
calcul
fluoroscopi
directli
measur
ct
later
diamet
significantli
p
wider
dorsoventr
diamet
cervic
mm
vs
mm
intrathorac
mm
vs
mm
trachea
indic
tracheal
shape
ellipsoid
circular
cervic
intrathorac
dorsoventr
tracheal
diamet
measur
ct
fluoroscopi
differ
p
p
respect
ct
csa
cervic
intrathorac
trachea
differ
fluoroscopi
p
tracheal
csa
significantli
reduc
cervic
intrathorac
apnea
compar
posit
pressur
p
tracheal
diamet
canin
tracheal
collaps
greater
later
dorsoventr
stent
size
dorsoventr
fluoroscopi
dimens
may
underestim
true
tracheal
csa
lead
risk
implant
tracheal
csa
dog
tracheal
collaps
affect
posit
airway
pressur
airway
csa
reduc
apnea
j
thomason
archer
press
mackin
mississippi
state
univers
starkvil
ms
hemolyt
anemia
imha
mortal
rate
around
dog
pulmonari
thromboembol
pte
common
caus
death
cyclosporin
becom
popular
agent
treatment
imha
howev
recent
research
dog
shown
immunosuppress
dosag
cyclosporin
increas
platelet
reactiv
increas
platelet
synthesi
thromboxan
aspirin
often
given
imha
patient
inhibit
platelet
synthesi
prevent
thromboembol
shown
decreas
mortal
rate
dog
imha
even
though
aspirin
commonli
given
concurr
cyclosporin
dog
imha
determin
aspirin
counteract
synthesi
altern
cyclosporin
counteract
effect
aspirin
studi
design
seven
healthi
young
adult
dog
given
either
aspirin
mgkg
hr
po
group
aspirin
mgkg
hr
po
group
cyclosporin
mgkg
hr
po
group
aspirin
combin
cyclosporin
group
day
washout
period
least
one
month
platelet
function
evalu
prior
day
day
therapi
use
turbidimetr
aggregometri
collagen
agonist
closur
time
collagenepinephrin
cartridg
urinari
level
measur
via
elisa
normal
urin
creatinin
concentr
aggregometri
perform
quadrupl
perform
duplic
urinari
level
analyz
triplic
result
averag
compar
baselin
day
aspirin
decreas
maxim
amplitud
aggregometri
day
respect
aspirin
decreas
maxim
amplitud
day
compar
baselin
cyclosporin
increas
maxim
amplitud
day
chang
baselin
day
group
maxim
amplitud
decreas
baselin
day
respect
day
closur
time
increas
baselin
group
respect
day
closur
time
increas
respect
day
urin
level
decreas
baselin
group
respect
increas
group
group
day
mean
urin
level
decreas
baselin
group
respect
increas
group
studi
confirm
aspirin
inhibit
platelet
function
albeit
extent
aspirin
demonstr
cyclosporin
significantli
alter
effect
aspirin
platelet
function
studi
also
confirm
cyclosporin
markedli
increas
platelet
thromboxan
synthesi
dog
cyclosporin
aspirin
given
concurr
cyclosporin
appear
significantli
reduc
effect
aspirin
inhibit
thromboxan
synthesi
investig
effect
concurr
cyclosporin
aspirin
platelet
reactiv
warrant
patient
risk
pte
k
k
e
g
mg
tennesse
colleg
veterinari
medicin
knoxvil
carolina
state
univers
raleigh
research
triangl
park
nc
gastrointestin
eros
ulcer
common
sequela
gastric
disord
cat
drug
mainstay
therapi
gener
tablet
contain
omeprazol
ot
famotidin
wide
avail
modifi
cat
owner
treat
pet
fraction
ot
famotidin
among
wide
prescrib
acid
suppress
howev
broken
effect
ot
rais
gastric
ph
may
significantli
compromis
moreov
studi
undertaken
cat
determin
efficaci
differ
acid
suppress
object
studi
compar
pharmacodynam
pharmacokinet
oral
omeprazol
formul
famotidin
cat
healthi
adult
cat
use
random
crossov
design
cat
receiv
mgkg
hr
fraction
omeprazol
tablet
omeprazol
past
dilut
cod
liver
oil
mgml
famotidin
tablet
twice
daili
placebo
lactos
capsul
intragastr
ph
monitor
bravo
use
continu
record
intragastr
ph
four
day
treatment
day
follow
washout
period
plasma
omeprazol
concentr
steadi
state
day
determin
hplc
ultraviolet
detect
mean
percentag
time
mpt
intragastr
ph
compar
among
group
use
anova
test
use
determin
group
differ
mpt
intragastr
ph
significantli
p
greater
cat
receiv
omeprazol
tablet
past
compar
famotidin
placebo
famotidin
significantli
differ
placebo
mean
sd
percentag
time
intragastr
ph
fraction
enter
ot
omeprazol
past
famotidin
placebo
mean
sd
plasma
omeprazol
concentr
day
steadi
state
similar
cat
receiv
tablet
compar
past
rang
associ
acid
suppress
studi
result
demonstr
omeprazol
formul
provid
superior
acid
suppress
cat
compar
famotidin
placebo
fraction
ot
effect
acid
suppress
despit
disrupt
enter
coat
jl
mm
r
v
school
veterinari
medicin
univers
california
androy
canin
research
center
aimargu
calcium
oxal
caox
common
urolith
submit
laboratori
dog
cat
pathophysiolog
caox
stone
format
poorli
understood
research
human
suggest
link
calcifi
nanoparticl
cnp
urolithiasi
cnp
compris
crystal
miner
organ
molecul
aggreg
size
urinari
cnp
alter
lithogen
patient
report
suggest
cnp
associ
presenc
randal
plaqu
furthermor
studi
human
report
alter
cnp
size
morpholog
aggreg
help
inhibit
calculu
format
patient
receiv
potassium
citrat
therapeut
drug
caox
manag
date
studi
evalu
cnp
small
anim
develop
flow
cytometri
protocol
detect
cnp
gener
vitro
confirm
particl
inde
apatit
base
transmiss
electron
microscopi
studi
nanoparticl
track
analysi
use
evalu
canin
urin
sampl
uniform
popul
particl
detect
exact
primari
cnp
size
rang
nm
furthermor
particl
similar
particl
contain
signific
amount
miner
fluoresc
marker
studi
ongo
develop
protocol
detect
cnp
urin
dog
futur
studi
anim
determin
abl
detect
urineplasma
cnp
cat
differ
cnp
quantiti
size
stabil
predict
lithogen
propens
cnp
assay
may
also
provid
tool
identifi
urinari
determin
crystal
aggreg
subsequ
stone
format
small
anim
e
furrow
jp
lulich
jr
mickelson
pj
armstrong
km
minor
ee
patterson
univers
minnesota
colleg
veterinari
medicin
st
paul
mn
object
studi
determin
hypercalciuria
underli
calcium
oxal
caox
urolith
risk
miniatur
schnauzer
ms
bichon
frise
bf
shih
tzu
st
identifi
suscept
gene
caox
urolithiasi
ms
use
associ
studi
gwa
ms
bf
st
case
histori
caox
urolith
control
yo
urolith
screen
radiograph
serum
fast
urinari
ratio
ucacr
ratio
uoxcr
measur
ms
dog
genotyp
snp
chip
gwa
sequenc
use
identifi
variant
within
locu
metabol
analys
includ
ms
case
control
bf
case
control
st
case
control
ms
bf
case
higher
serum
control
p
though
valu
within
refer
interv
breed
case
higher
ucacr
control
p
uoxcr
differ
gwa
includ
ms
case
control
strong
associ
signal
present
chromosom
praw
pgenom
sequenc
result
evalu
gene
critic
region
code
variant
identifi
put
regulatori
variant
found
solut
carrier
gene
knockdown
gene
drosophila
caox
model
increas
stone
volum
hypercalciuria
associ
caox
urolithiasi
canin
breed
genet
map
ms
dog
identifi
potenti
caox
suscept
gene
j
j
j
j
j
c
minnesota
st
paul
state
univers
e
lans
pet
nutrit
inc
topeka
statist
consult
inc
lincoln
ne
calcium
oxal
caox
urolith
account
approxim
felin
stone
submiss
minnesota
urolith
center
date
studi
follow
affect
cat
long
term
determin
rate
recurr
confound
factor
effect
dietari
intervent
studi
random
control
studi
examin
food
manag
caox
urolithiasi
compar
control
ctl
food
test
food
contain
greater
amount
fatti
acid
less
ca
mg
target
urin
ph
ctl
food
design
similar
popular
groceri
brand
target
urin
ph
food
otherwis
similar
met
minimum
aafco
requir
adult
cat
protocol
acuc
approv
cat
recent
histori
confirm
caox
urolith
recruit
owner
given
choic
food
form
wet
dri
combin
cat
random
onto
test
ctl
food
cat
evalu
month
interv
physic
examin
abdomin
radiographi
urinalys
serum
chemistri
urin
collect
chemistri
rel
super
satur
rss
calcul
conduct
month
detect
stone
recurr
data
analyz
factori
combin
food
hypercalcemia
hca
recurr
cat
recruit
test
ctl
complet
studi
includ
analysi
intermitt
hca
hca
detect
test
food
ctl
food
fed
cat
stone
recurr
observ
cat
overal
detect
test
food
ctl
food
fed
cat
rss
caox
urin
ca
significantli
higher
cat
stone
recurr
cat
fed
control
food
cat
hca
signific
p
interact
hca
food
observ
rss
caox
least
squar
mean
rss
caox
sem
nonhcatest
hcatest
nonhcactl
hcactl
urin
ph
significantli
differ
food
cat
hca
stone
recurr
result
suggest
recurr
caox
urolith
hca
may
lower
cat
fed
nutrit
test
food
affect
may
due
mitig
effect
test
food
urin
calcium
recurr
caox
urolithiasi
multifactori
occult
hca
may
play
larger
role
diseas
typic
recogn
jm
hm
iv
j
pet
nutrit
inc
topeka
inc
raleigh
nc
calcium
oxal
caox
urolithiasi
account
approxim
case
urolithiasi
cat
cat
like
reform
stone
within
yr
therefor
need
develop
test
routin
predict
risk
cat
may
form
reform
stone
provid
feedback
given
intervent
lower
risk
rel
super
satur
rss
regard
best
method
evalu
urin
howev
test
commerci
avail
veterinari
commun
labor
intens
costli
rss
softwar
date
version
avail
one
proprietari
yield
result
differ
equil
rss
use
limit
number
metabolit
fulli
evalu
complex
system
urin
mani
promot
inhibitor
interact
rss
limit
abil
predict
propens
urin
form
stone
human
bonn
risk
index
use
whole
urin
better
reflect
risk
stone
format
calcium
oxal
risk
index
cori
similar
principl
human
bonn
risk
index
briefli
whole
urin
titrat
sodium
oxal
solut
precipit
occur
cori
valu
determin
divid
urin
result
amount
oxal
ad
point
precipit
panel
healthi
adult
cat
use
acuc
approv
studi
cat
individu
hous
group
exercis
social
interact
spaciou
room
natur
light
cat
fed
seri
differ
food
vari
nutrit
profil
day
cours
year
food
vari
form
dri
wet
alway
fed
maintain
bodi
weight
urin
collect
perform
day
equil
softwar
use
calcul
rss
urin
concentr
citrat
creatinin
oxal
k
na
urin
ph
version
use
analysi
caox
rss
cori
result
moder
correl
r
p
rss
caox
weakli
correl
urin
ph
r
p
rss
struvit
p
cori
howev
correl
either
urin
ph
r
p
rss
struvit
r
p
nutrit
profil
food
individu
urinari
constitu
analyz
determin
driver
rss
caox
cori
cori
test
provid
sever
advantag
rss
caox
potenti
commerci
avail
test
provid
veterinarian
pet
owner
rapid
feedback
concern
success
intervent
importantli
use
whole
urin
take
account
entir
milieu
urinari
constitu
affect
propens
form
calcium
oxal
stone
work
continu
determin
impact
nutrit
previou
stone
statu
cori
mp
littman
mg
raducha
ps
henthorn
univers
pennsylvania
school
veterinari
medicin
philadelphia
pa
previous
show
nephropathi
pln
wheaten
terrier
scwt
associ
variant
allel
linkag
dysequilibrium
two
adjac
gene
encod
slit
diaphragm
protein
nephrin
respect
scwt
homozyg
posit
dog
highest
risk
heterozyg
dog
intermedi
risk
homozyg
neg
dog
lowest
risk
develop
pln
among
dog
breed
dog
airedal
bloodhound
show
allel
includ
one
homozyg
posit
airedal
terrier
die
pln
cheek
swab
blood
semen
sampl
dna
test
airedal
terrier
median
age
yr
wide
dispers
region
unit
state
canada
studi
preval
allel
airedal
breed
determin
breeder
safe
remov
carrier
dog
one
gener
result
haplotyp
frequenc
tabul
genet
counsel
would
benefit
airedal
commun
help
breeder
avoid
produc
homozyg
posit
dog
jm
quimbi
tl
webb
e
randal
marolf
sw
dow
center
immun
regen
medicin
depart
clinic
scienc
colorado
state
univers
fort
collin
co
felin
chronic
kidney
diseas
ckd
character
chronic
tubulointerstiti
nephriti
inflamm
contribut
progress
renal
fibrosi
mesenchym
stem
cell
msc
demonstr
effect
rodent
ckd
model
purpos
studi
evalu
use
allogen
msc
treatment
felin
ckd
msc
isol
cryopreserv
adipos
spf
research
cat
ckd
cat
enrol
blind
crossov
clinic
studi
four
ckd
cat
random
receiv
x
msckg
intraven
week
three
ckd
cat
random
receiv
placebo
one
cat
cross
msc
treatment
group
cbc
chemistri
urinalysi
perform
week
glomerular
filtrat
gfr
via
nuclear
scintigraphi
upc
perform
zero
week
five
cat
receiv
dose
fresh
msc
without
advers
effect
signific
chang
serum
creatinin
gfr
upc
pcv
seen
cat
treat
msc
individu
chang
gfr
treat
cat
compar
control
cat
discord
creatinin
gfr
result
observ
treat
cat
experienc
greatest
decreas
creatinin
also
experienc
greatest
declin
gfr
administr
msc
expand
cryopreserv
adipos
associ
side
effect
howev
discern
immedi
improv
renal
function
appreci
follow
necessari
determin
effect
progress
diseas
ca
g
ld
j
z
e
davi
school
veterinari
medicin
davi
school
veterinari
medicin
hebrew
univers
jerusalem
laboratori
inc
westbrook
key
factor
high
mortal
rate
associ
acut
kidney
injuri
aki
dog
lack
sensit
test
identifi
earli
stage
diseas
novel
urinari
serum
biomark
may
identifi
aki
earlier
tradit
marker
urinari
clusterin
uclusterin
apolipoprotein
overexpress
renal
tubular
injuri
elev
correl
damag
sever
serum
inosin
sinosin
metabolit
adenosin
deamin
produc
proxim
tubular
cell
health
purpos
studi
evalu
util
uclusterin
sinosin
earli
aki
diagnosi
canin
model
aki
aki
induc
dog
gentamicin
administr
mgkg
sc
q
hour
serum
creatinin
screatinin
sinosin
uclusterin
measur
twice
daili
aki
induct
aki
defin
increas
screatinin
baselin
occur
median
day
rang
day
compar
median
uclusterin
increas
valu
ngml
median
day
rang
day
p
baselin
median
uclusterin
ngml
rang
ngml
peak
ngml
rang
ngml
median
day
increas
baselin
median
baselin
sinosin
ugdl
rang
ugdl
declin
steepli
follow
gentamicin
administr
dog
decreas
median
day
median
day
gentamicin
induc
canin
model
aki
chang
uclusterin
sinosin
preced
chang
screatinin
novel
marker
show
promis
earli
aki
detect
dog
bdx
b
k
pain
research
compar
medicin
translat
research
ncsu
cvm
raleigh
melbourn
australia
critic
need
proven
drug
drug
treatment
degen
joint
diseas
djd
pain
dog
antibodi
nerv
growth
factor
ngf
analges
rodent
model
human
djd
pilot
studi
aim
evalu
efficaci
novel
caninis
antibodi
treatment
djd
pain
dog
mask
clinic
studi
dog
djd
random
mcgkg
iv
placebo
addit
object
accelerometri
measur
owner
complet
clinic
metrolog
instrument
outcom
measur
csom
canin
brief
pain
inventori
cbpi
day
csom
cbpi
subscal
pain
sever
ps
pain
interfer
pi
evalu
within
group
recogn
successfailur
criteria
appli
success
compar
group
cbpi
ps
pi
score
significantli
improv
group
ps
day
p
day
p
pi
day
p
day
p
placebo
group
csom
score
show
similar
pattern
signific
differ
group
day
day
p
p
respect
significantli
success
day
p
side
effect
note
object
measur
activ
significantli
increas
group
p
placebo
group
p
pilot
data
demonstr
posit
analges
effect
antibodi
dog
suffer
chronic
pain
magnitud
effect
ident
expect
nsaid
ls
g
sobol
dp
lk
ej
faculti
colleg
veterinari
medicin
univers
munich
state
univers
east
lans
carolina
state
univers
raleigh
state
univers
stillwat
state
univers
fort
collin
co
equid
herpesviru
type
caus
respiratori
diseas
equid
myelopathi
ehm
late
term
abort
chorioretinopathi
hors
follow
infect
respiratori
tract
viremia
often
establish
lead
viru
dissemin
endotheli
cell
ec
infect
spinal
cord
vasculatur
pregnant
uteru
eye
previous
show
focal
multifoc
shotgun
lesion
experiment
infect
hors
week
post
infect
pi
base
data
hypothesi
eye
lesion
caus
ec
infect
result
vascul
similar
occur
ehm
incid
ehm
correl
incid
ocular
lesion
test
hypothesi
mix
breed
hors
age
year
infect
strain
euthan
day
pi
clinic
sign
neurolog
diseas
evalu
day
post
infect
eye
collect
post
euthanasia
addit
eye
yearl
hors
develop
acut
neurolog
sign
follow
experiment
infect
strain
one
eye
geld
develop
neurolog
sign
ehv
ogden
ut
outbreak
collect
neurolog
gait
abnorm
hors
score
scale
abnorm
sever
abnorm
addit
ocular
tissu
process
colorado
state
univers
histolog
section
collect
stain
h
e
immunohistochemistri
ihc
perform
use
antibodi
eye
lesion
describ
degre
choroiditisvascul
cv
score
accord
sever
frequenc
scale
lesion
abund
lesion
correl
coeffici
eye
lesion
score
clinic
neurolog
gait
abnorm
determin
differ
consid
signific
yearl
hors
sever
frequent
cv
hors
grade
hors
grade
hors
grade
ihc
posit
yearl
hors
posit
occas
clinic
neurolog
gait
abnorm
score
infect
experi
correl
well
eye
lesion
summari
pathogenesi
ocular
ehm
might
similar
viral
antigen
detect
infect
hors
signific
correl
neurolog
diseas
ocular
diseas
detect
lack
viral
antigen
eye
hors
exhibit
neurolog
diseas
may
due
time
point
euthanasia
lack
sensit
assay
select
ga
perkin
lb
goodman
babasyan
h
freer
keggan
glaser
v
svansson
ba
wagner
cornel
univers
colleg
veterinari
medicin
ithaca
ny
foal
respond
poorli
exist
vaccin
optim
adult
immun
system
hypothesi
foal
protect
infect
vaccin
activ
independ
memori
antibodi
product
iceland
consid
free
pregnant
iceland
mare
import
isol
facil
februari
foal
born
spring
suckl
colostrum
free
matern
antibodi
foal
either
receiv
equin
ige
birth
nasogastr
tube
day
later
recombin
glycoprotein
c
gc
antigen
intramuscularli
im
receiv
gc
antigen
im
day
life
receiv
treatment
age
foal
wean
infect
physic
examin
done
daili
viral
dna
gc
antibodi
measur
blood
nasal
secret
infect
repeat
measur
anova
dunn
compar
individu
group
done
foal
develop
fever
pi
vaccin
foal
significantli
lower
temperatur
p
dna
detect
qpcr
nasal
swab
first
week
pi
signific
differ
group
serum
nasal
gc
antibodi
increas
day
pi
significantli
higher
magnitud
vaccin
foal
p
novel
equin
neonat
vaccin
provid
protect
clinic
diseas
prepar
foal
adapt
immun
system
respond
rapidli
robustli
infect
hl
g
sobol
l
ga
state
univers
fort
collin
state
univers
east
lans
mi
equin
influenza
viru
eiv
import
equin
respiratori
pathogen
continu
caus
diseas
suffer
hors
order
design
effect
eiv
control
strategi
crucial
understand
invok
protect
immun
system
igg
titer
long
use
correl
protect
eiv
infect
system
antibodi
titer
alway
accur
predictor
clinic
protect
viru
mlv
vaccin
fluavert
merck
anim
health
induc
weak
system
antibodi
respons
despit
vaccin
shown
provid
clinic
protect
month
singl
vaccin
administr
suggest
mechan
humor
respons
critic
import
eiv
immun
adapt
immun
eiv
well
character
lack
inform
regard
innat
immun
respons
occur
airway
epithelium
eiv
infect
object
studi
compar
innat
immun
respons
primari
equin
respiratori
epitheli
cell
erec
cultur
follow
infect
either
mlv
vaccin
strain
close
relat
eiv
strain
eqki
hypothesi
infect
mlv
vaccin
strain
elicit
similar
innat
immun
respons
equin
airway
cell
seen
follow
infect
viru
equin
airway
epitheli
cell
collect
upper
lower
respiratori
tract
respiratori
healthi
anim
cell
grown
interfac
fulli
differenti
subsequ
cell
cultur
inocul
multipl
infect
moi
either
mlv
strain
eqki
incub
either
twelv
hr
inocul
cell
cultur
subnat
cell
collect
assay
protein
mrna
express
inocul
erec
either
viru
result
mrna
cytokin
express
degre
depend
viru
strain
site
cell
collect
upper
versu
lower
respiratori
tract
incub
temperatur
use
moreov
express
level
appear
associ
viral
replic
effici
result
highlight
fact
immun
influenza
viru
multifacet
involv
sever
arm
host
immun
respons
whether
innat
mechan
play
role
observ
clinic
protect
follow
intranas
vaccin
mlv
vaccin
remain
investig
n
dp
raleigh
nc
workshop
held
novemb
addi
ababa
ethiopia
attend
intern
deleg
repres
academia
ngo
oie
govern
agenc
goal
identifi
way
reduc
burden
infecti
diseas
work
equid
worldwid
size
work
equid
popul
estim
million
world
domest
equid
popul
although
may
significantli
true
popul
major
work
equid
live
countri
major
role
livelihood
household
inform
occurr
infecti
diseas
popul
often
incomplet
clear
evid
wide
region
distribut
high
morbid
mortal
includ
african
hors
sick
eia
influenza
rabi
tetanu
glander
burkholderia
mallei
epizoot
lymphang
piroplasmosi
trypanosomiasi
gi
nematod
importantli
participatori
survey
equid
owner
observ
field
worker
identifi
respiratori
neurolog
diseas
syndrom
high
impact
warrant
investig
strategi
equin
diseas
surveil
lack
diagnost
infrastructur
contrast
speci
region
systemat
data
gather
coupl
new
indic
diseas
impact
need
progress
understand
equin
ecolog
repeatedli
demonstr
critic
diseas
control
promot
control
measur
adopt
owner
educ
top
prioriti
workshop
made
two
key
set
recommend
first
regard
impedi
progress
fell
three
categori
technic
lack
data
includ
equid
number
movement
diseas
surveil
behavior
princip
lack
equin
manag
educ
understand
impact
institut
princip
lack
equin
statu
affect
aspect
resourc
alloc
second
set
recommend
regard
address
diseas
challeng
three
categori
first
set
diseas
major
technic
barrier
progress
limit
need
advocaci
address
behavior
institut
barrier
progress
exampl
includ
african
hors
sick
tetanu
second
set
diseas
signific
knowledg
technic
barrier
remain
addit
behavior
institut
barrier
research
urgent
need
address
gap
exampl
includ
epizoot
lymphang
blood
born
parasit
third
set
diseas
repres
essenti
syndrom
diagnos
requir
thorough
investig
renew
surveil
determin
diagnosi
high
degre
certainti
need
opportun
reduc
infecti
diseas
work
equid
enorm
increas
global
local
advocaci
base
equin
welfar
impact
essenti
success
global
network
investig
play
critic
role
build
region
capac
toward
address
need
c
cruz
l
amels
n
neilsen
dhar
univers
tennesse
colleg
veterinari
medicin
knoxvil
tn
peripher
nerv
injuri
caus
poor
perform
hors
injuri
difficult
manag
treatment
mostli
reli
physic
therapi
howev
long
term
effect
time
personnel
consum
object
test
abil
equin
mesenchym
stromal
cell
msc
differenti
neuron
lineag
subsequ
schwann
cell
nerv
regener
bone
msc
obtain
young
adult
hors
follow
demonstr
stem
cell
neuron
induc
tissu
cultur
plate
microscop
assess
h
result
show
plate
support
prolifer
differenti
surviv
improv
high
number
cell
morpholog
chang
observ
earli
hour
h
approxim
cell
morpholog
similar
hors
prolifer
variabl
protein
concentr
influenc
cell
number
method
protein
extract
express
neuron
progenitor
protein
vimentin
tubulin
gfap
detect
immunoblot
analysi
nestin
evid
result
demonstr
equin
msc
differenti
neuron
lineag
futur
work
aim
cell
schwann
cell
evalu
surviv
peripher
nerv
express
schwann
cell
specif
marker
test
aj
stewart
j
costello
dm
booth
sh
duran
ad
ramo
fb
cesar
colleg
veterinari
medicin
auburn
univers
auburn
al
levetiracetam
lev
novel
drug
purpos
determin
disposit
pioneer
vers
gener
levetiracetam
hors
six
healthi
adult
hors
administ
mgkg
po
pioneer
gener
lev
design
serum
csf
sampl
collect
hr
pioneer
n
hr
n
hr
n
gener
formul
lev
concentr
analyz
via
immunoassay
pharmacokinet
paramet
compar
use
pair
p
consid
statist
signific
pioneer
gener
formul
maximum
concentr
cmax
similar
within
serum
p
csf
p
respect
predict
area
curv
infin
auc
pioneer
gener
formul
serum
similar
hr
p
auc
pioneer
administr
csf
hr
administr
pioneer
cmax
auc
mean
resid
time
mrt
appar
volum
distribut
vzf
appar
clearanc
cl
greater
csf
serum
tmax
greater
csf
serum
gener
pioneer
lev
formul
consid
similar
may
make
use
levetiracetam
afford
treatment
seizur
hors
lk
maxwel
tc
holbrook
gilliam
gb
rezabek
r
eberl
ta
snider
mcfarlan
ca
jamieson
kievitsbosch
dh
black
oklahoma
state
univers
stillwat
ok
previou
work
demonstr
age
hors
suscept
equin
herpesviru
myeloencephalopathi
ehm
young
hors
howev
basi
differ
yet
establish
object
work
determin
whether
immunocompet
blood
brain
barrier
permeabl
contribut
suscept
hors
ehm
hypothes
decreas
immun
induc
cyclosporin
administr
increas
suscept
ehm
increas
permeabl
blood
brain
barrier
bbb
induc
mannitol
lipopolysaccharid
administr
enhanc
suscept
ehm
sixteen
hors
mare
geld
age
year
random
treatment
group
cyclosporin
bbb
disrupt
cyclosporin
plu
bbb
disrupt
untreat
control
hors
inocul
intranas
equin
herpesviru
type
hors
assess
day
dpi
signific
find
bodi
temperatur
nasal
shed
differ
group
p
viremia
higher
dpi
cyclosporin
treat
hors
compar
control
hors
p
viral
load
neurolog
tissu
higher
hors
cyclosporin
administ
p
maximum
ataxia
clinic
score
higher
hors
cyclosporin
administ
significantli
p
respect
studi
suggest
immunocompet
import
pathogenesi
ehm
young
hors
bbb
integr
studi
warrant
determin
aspect
immun
respons
affect
cyclosporin
administr
necessari
develop
ehm
ln
wise
l
kappmey
knowl
washington
state
univers
pullman
wa
recent
routin
hors
surveil
south
texa
includ
serolog
test
theileria
equi
identifi
stray
hors
inconsist
result
commerci
avail
competit
elisa
addit
test
perform
hors
neg
equi
celisa
pcr
ifa
transfer
blood
splenectom
hors
result
equi
infect
rrna
analysi
confirm
infect
theileri
speci
almost
ident
isol
hors
zebra
south
africa
analysi
show
isol
quit
differ
equi
isol
identifi
date
north
america
genom
sequenc
complet
technolog
pair
bac
end
read
de
novo
assembl
numer
differ
note
isol
genom
domest
equi
particular
interest
ema
equi
merozoit
antigen
gene
famili
gene
famili
encod
immunodomin
surfac
merozoit
ema
protein
antibodi
protein
util
diagnost
test
equi
variant
possess
diverg
ema
famili
member
explain
inconsist
test
result
implic
identifi
variant
within
us
extens
genet
work
describ
serv
basi
research
parasit
sl
sullivan
ga
anderson
whittem
ps
morley
kw
hinchcliff
univers
melbourn
victoria
australia
colleg
veterinari
medicin
colorado
state
univers
fort
collin
colorado
usa
frusemid
commonli
use
medic
eiph
howev
critic
evalu
strength
evid
efficaci
frusemid
lack
object
systemat
review
evalu
use
frusemid
reduc
sever
frequenc
detect
eiph
thoroughbr
racehors
studi
identifi
via
search
electron
databas
relev
text
refer
list
publish
articl
studi
restrict
languag
date
public
statu
search
term
includ
exercis
induc
pulmonari
h
morrhag
f
semid
treatment
hors
equin
includ
studi
randomis
non
randomis
trial
prospect
observ
studi
experiment
studi
data
extract
perform
one
author
three
author
independ
assess
studi
use
grade
recommend
rate
qualiti
evid
studi
perform
random
effect
model
determin
frusemid
reduc
frequenc
detect
eiph
ye
frusemid
reduc
sever
eiph
least
tracheobronchoscop
grade
stata
medcalc
perform
analys
seventeen
studi
fulfil
inclus
criteria
provid
data
frusemid
reduc
risk
detect
eiph
pool
data
studi
n
rr
ci
p
signific
heterogen
exist
p
explain
includ
studi
design
pair
unpair
p
data
two
rct
pair
design
use
rr
hors
treat
frusemid
ci
p
proport
hors
diagnos
eiph
control
treatment
reduct
least
eiph
grade
frusemid
ci
methodolog
robust
trial
use
valid
outcom
measur
hors
target
popul
indic
frusemid
reduc
frequenc
sever
eiph
compar
untreat
hors
hors
administ
salin
placebo
n
c
rl
k
p
c
k
j
r
l
j
l
j
kg
veterinari
medicin
univers
california
davi
equin
clinic
san
antonio
veterinari
clinic
elkhorn
hill
veterinari
servic
orinda
veterinari
servic
ipswich
england
equin
medic
surgic
center
dover
veterinari
clinic
petaluma
jersey
equin
associ
vineland
equin
hospit
nampa
basin
equin
medic
center
penryn
ca
equin
coronaviru
ecov
identifi
electron
microscopi
cultur
recent
pcr
fece
foal
without
enter
diseas
two
recent
studi
report
isol
ecov
fece
hors
pyrogen
enter
diseas
live
stabl
racetrack
japan
howev
littl
known
ecov
especi
regard
molecular
diagnost
field
sampl
clinic
signific
ecov
pcr
posit
fecal
result
purpos
studi
describ
clinic
hematolog
fecal
pcr
result
hors
involv
outbreak
associ
ecov
outbreak
happen
eight
separ
board
facil
novemb
novemb
state
ca
tx
wi
nj
id
popul
hors
per
stabl
rang
hors
follow
molecular
detect
ecov
fece
initi
index
case
remain
herdmat
close
observ
develop
clinic
sign
fecal
sampl
collect
sick
healthi
hors
pcr
detect
ecov
clinic
patholog
sick
hors
evalu
avail
eight
outbreak
involv
primarili
adult
hors
eighti
hors
develop
clinic
sign
sick
hors
per
outbreak
main
clinic
sign
report
anorexia
lethargi
fever
diarrhea
colic
observ
hors
respect
hors
develop
acut
onset
encephalopathi
clinic
sign
gener
resolv
within
day
support
care
nine
hors
six
differ
outbreak
euthan
die
due
rapid
progress
clinic
sign
caus
death
hors
attribut
endotoxem
shock
septicemia
metabol
derang
blood
work
avail
hors
common
hematolog
abnorm
neutropenia
andor
lymphopenia
fece
avail
ecov
test
pcr
sick
healthi
hors
respect
overal
agreement
clinic
statu
pcr
detect
ecov
conclus
ecov
infect
adult
hors
gener
associ
clinic
hematolog
abnorm
although
compromis
intestin
barrier
lead
sever
secondari
complic
death
ecov
infect
support
posit
fecal
pcr
result
lm
jt
da
sa
dj
k
j
jc
memori
univers
colleg
veterinari
medicin
harrog
tennesse
knoxvil
ltd
athen
ga
purpos
studi
evalu
safeti
immunolog
activ
plasmid
hors
diagnos
melanoma
vaccin
previous
report
effect
treat
melanoma
dog
accomplish
goal
propos
studi
wherein
vaccin
use
gradual
escal
dose
hors
diagnos
melanoma
tempor
measur
immunolog
respons
treat
patient
protocol
involv
treat
total
hors
seri
inject
along
booster
biolog
sampl
collect
protocol
measur
antibodi
vitro
cellular
reactiv
human
tyrosinas
cellular
reactiv
equin
tyrosinas
final
character
tumor
infiltr
lymphocyt
popul
advers
reaction
seen
vaccin
patient
object
respons
seen
treat
hors
posit
humor
respons
seen
treat
hors
cellular
reactiv
note
treat
patient
character
tumor
infiltr
lymphocyt
popul
identifi
statist
signific
increas
lymphocyt
along
decreas
regulatori
cell
follow
vaccin
increas
plasmid
dose
appear
associ
increas
either
clinic
activ
immunolog
reactiv
xenogen
vaccin
appear
safe
well
toler
tumor
bear
hors
appear
result
clinic
activ
measur
immun
respons
treat
patient
l
duffe
ag
boyl
rc
boston
univers
pennsylvania
new
bolton
center
kennett
squar
pa
strangl
contagi
acut
infect
upper
respiratori
tract
caus
streptococcu
equi
hors
multipl
outbreak
retrospect
studi
examin
risk
factor
strangl
diagnosi
preval
diseas
complic
computer
field
servic
medic
record
examin
strangl
case
select
base
presenc
classic
clinic
sign
fever
lymphadenopathi
nasal
discharg
confirm
outbreak
posit
equi
pcr
aerob
cultur
control
case
select
presenc
fever
time
period
data
collect
includ
signal
clinic
sign
diagnost
test
therapi
diseas
complic
hematolog
valu
analyz
descript
regress
statist
method
signific
risk
factor
p
strangl
diagnosi
includ
year
old
presenc
fever
nasal
discharg
extern
abscess
hyperfibrinogenemia
mgdl
anemia
leukocytosi
cellsul
trend
toward
strangl
diagnosi
contrari
previou
report
fever
extern
abscess
found
case
respect
hors
test
prior
treatment
pcr
posit
absenc
extern
clinic
sign
studi
show
higher
preval
purpura
hemorrhagica
prolong
day
equi
pcr
posit
hors
lower
preval
metastat
diseas
previous
report
fever
abscess
may
insuffici
diseas
screen
use
alon
clinic
sign
diseas
complic
rate
observ
multipl
outbreak
differ
previous
publish
data
ka
sd
nm
bs
ohio
state
univers
colleg
veterinari
medicin
columbu
oh
usa
equin
medic
institut
lexington
ky
usa
riddl
equin
hospit
lexington
ky
usa
axi
hpaa
dysfunct
rel
adren
insuffici
rai
associ
sepsi
mortal
newborn
foal
howev
comprehens
inform
adren
cortex
respons
sepsi
sick
foal
limit
studi
focus
cortisol
essenti
adrenocort
steroid
steroid
precursor
neurosteroid
overlook
hypothes
adren
steroid
precursor
neurosteroid
concentr
higher
sick
compar
healthi
foal
admiss
remain
unchang
increas
next
h
hospit
septic
foal
hormon
delta
steroid
concentr
associ
sever
diseas
mortal
rate
blood
sampl
collect
admiss
time
h
time
septic
sick
sn
healthi
foal
day
age
blood
concentr
corticoliberin
crh
adrenocorticotropin
acth
cortisol
aldosteron
pregnenolon
progesteron
androstenedion
dehydroepiandrosteron
dhea
allopregnanolon
determin
immunoassay
delta
steroid
defin
steroid
concentr
differ
time
cortisol
acth
crh
concentr
higher
septic
healthi
foal
time
p
septic
foal
higher
crh
acth
cortisol
aldosteron
pregnenolon
progesteron
androstenedion
dhea
concentr
compar
sn
healthi
foal
time
p
differ
allopregnenolon
concentr
foal
group
delta
pregnenolon
lower
delta
crh
higher
septic
compar
healthi
foal
healthi
foal
lower
aldosteron
pregnenolon
time
compar
time
hospit
foal
higher
crh
acth
cortisol
progesteron
concentr
compar
surviv
foal
time
aldosteron
pregnenolon
concentr
higher
foal
die
time
point
p
adrenocort
respons
sepsi
foal
character
persist
increas
steroid
concentr
first
h
hospit
foal
steroid
increas
admiss
like
die
aldosteron
pregnenolon
progesteron
concentr
good
predictor
admiss
h
hospit
foal
de
kj
lr
va
veterinari
health
scienc
oklahoma
state
univers
stillwat
bolton
center
univers
pennsylvania
kennett
squar
pa
equin
metabol
syndrom
character
obes
insulin
resist
ir
current
effect
pharmacolog
treatment
insidi
diseas
glucos
uptak
mediat
famili
glucos
transport
glut
regul
pathway
includ
protein
kinas
ampk
importantli
downregul
ampk
implic
pathogenesi
ir
addit
activ
ampk
aicar
stimul
glucos
uptak
healthi
diabet
human
howev
whether
aicar
promot
glucos
uptak
hors
establish
blood
sampl
gluteal
muscl
biopsi
obtain
healthi
hors
hour
follow
intraven
aicar
infus
protein
express
major
glut
total
phosphoryl
ampk
quantifi
western
blot
skelet
muscl
treatment
aicar
result
decreas
p
blood
glucos
concentr
increas
p
insulin
concentr
trend
toward
increas
skelet
muscl
protein
content
total
phosphoryl
ampk
p
respect
hour
treatment
protein
express
remain
unchang
increas
p
follow
aicar
treatment
upregul
protein
express
aicar
suggest
novel
glut
isoform
play
import
role
equin
muscl
glucos
transport
addit
data
suggest
ampk
activ
enhanc
pancreat
insulin
secret
collect
data
suggest
aicar
acut
promot
muscl
glucos
uptak
hors
thu
therapeut
potenti
manag
ir
requir
investig
ne
rj
rk
veterinari
medicin
univers
minnesota
st
paul
veterinari
medicin
michigan
state
univers
east
lans
polytechn
institut
state
univers
blacksburg
va
hyperinsulinemia
insulin
resist
compon
equin
metabol
syndrom
em
condit
associ
predisposit
lamin
develop
incretin
play
key
role
glucos
homeostasi
insulin
secretori
respons
incretin
hormon
produc
endocrin
cell
gastrointestin
tract
promot
releas
insulin
respons
oral
sugar
administr
short
due
rapid
inactiv
enzym
dipeptidyl
object
investig
variabl
equin
incretin
respons
identifi
factor
associ
incretin
respons
variat
glucos
glu
insulin
in
total
activ
concentr
determin
morgan
hors
welsh
poni
farm
baselin
minut
follow
oral
sugar
challeng
baselin
activ
prior
lamin
statu
obes
statu
bodi
condit
score
bc
age
breed
sex
diet
measur
also
collect
repeat
measur
quadrat
random
regress
analysi
perform
respect
time
independ
variabl
includ
time
age
breed
sex
obesitylamin
statu
baselin
activ
diet
variabl
farm
also
includ
random
effect
signific
curv
detect
popul
mean
glu
in
peak
estim
occur
minut
respect
signific
posit
correl
detect
insglu
baselin
glu
correl
posit
obes
statu
hors
higher
daili
calor
intak
lower
glu
rate
chang
time
baselin
in
posit
correl
age
activ
obes
prior
lamin
statu
significantli
lower
geld
baselin
neg
correl
total
daili
calor
intak
associ
significantli
higher
respons
time
contrast
starch
posit
correl
baselin
result
significantli
lower
rate
chang
time
baselin
significantli
higher
stallion
geld
howev
significantli
lower
rate
chang
time
stallion
baselin
measur
activ
significantli
greater
welsh
poni
neg
correl
age
find
indic
hors
exhibit
chang
blood
insulin
glucos
concentr
follow
oral
sugar
challeng
characterist
incretin
respons
signific
factor
associ
variat
respons
includ
activ
obes
statu
gender
dietari
factor
ba
burgess
ps
morley
depart
clinic
scienc
colleg
veterinari
medicin
biomed
scienc
colorado
state
univers
fort
collin
co
salmonella
enterica
one
common
caus
healthcar
associ
infect
veterinari
teach
hospit
common
caus
equin
hospit
closur
among
top
three
agent
associ
ill
veterinari
personnel
salmonella
spread
among
patient
environment
contamin
predict
present
whether
caus
effect
addit
subclin
infect
shed
absenc
diseas
much
common
clinic
infect
unfortun
current
detect
method
gener
lack
sensit
prolong
time
detect
consequ
risk
recognit
abil
rapidli
identifi
patient
environment
contamin
critic
effect
manag
popul
environ
object
project
determin
factor
associ
shed
enterica
among
gener
inpati
popul
associ
environment
contamin
time
endem
diseas
purpos
endem
epidem
diseas
prevent
march
decemb
fecal
cultur
perform
larg
anim
inpati
n
admiss
twice
weekli
hospit
environment
cultur
perform
monthli
predetermin
locat
throughout
facil
n
variabl
character
patient
popul
hospit
collect
retrospect
electron
medic
record
databas
multivari
logist
regress
use
evalu
associ
factor
interest
patient
shed
enterica
associ
environment
contamin
studi
period
approxim
n
patient
fecal
cultur
posit
enterica
major
bovin
equin
addit
approxim
n
environment
sampl
use
standard
cultur
techniqu
gener
indic
sever
diseas
relat
patient
shed
environment
sampl
collect
livestock
hospit
floor
surfac
time
high
caseload
like
posit
factor
identifi
studi
permit
refin
exist
infect
control
program
provid
better
understand
epidemiolog
salmonella
veterinari
hospit
allow
evid
base
prevent
measur
implement
infect
control
program
daili
basi
kapil
oklahoma
anim
diseas
diagnost
laboratori
center
veterinari
health
scienc
stillwat
ok
bovin
lymphotrop
herp
viru
blhv
member
herpesvirida
famili
subfamili
gammaherpesvirina
report
detect
blhv
dna
specimen
submit
oaddl
role
blhv
clinic
case
cattl
report
partial
blhv
herpesviru
dna
base
pair
detect
use
pan
herp
viru
pcr
confirm
sequenc
analysi
conserv
polymeras
gene
herp
virus
use
blastn
analysi
total
bovin
specimen
fresh
tissu
collect
necropsi
includ
brain
n
lung
n
specimen
n
ant
mortem
specimen
includ
nasal
swab
n
eye
swab
n
blood
n
test
small
number
specimen
csf
also
test
specimen
collect
respiratori
nervou
tissu
posit
neg
clinic
sign
histopatholog
lesion
sudden
death
high
fever
neurolog
diseas
respiratori
diseas
small
number
normal
nasal
swab
also
test
clinic
normal
cattl
blhv
dna
detect
pcr
specimen
eight
state
usa
base
find
conclud
blhv
detect
pan
herp
viru
pcr
respiratori
nervou
tissu
specimen
base
detect
steril
tissu
brain
presenc
sever
lesion
histopatholog
perivascular
cuf
conclud
blhv
pathogen
cattl
sudden
death
nervou
diseas
howev
role
blhv
upper
respiratori
tract
diseas
base
nasal
swab
still
unclear
blhv
detect
nasal
caviti
clinic
normal
cattl
also
howev
role
blhv
case
bovin
pneumonia
support
presenc
sever
chronic
lesion
interstiti
pneumonia
e
faculti
univers
bern
engin
laboratori
faculti
appli
scienc
univers
bern
biel
tropic
public
health
institut
univers
basel
basel
switzerland
cecal
dilatationdisloc
cdd
common
econom
import
abdomin
disord
affect
mainli
dairi
cattl
wherea
clinic
aspect
cdd
well
describ
pathogenesi
diseas
remain
poorli
understood
therefor
adequ
recommend
prevent
diseas
remain
elus
primari
motil
disturb
spiral
colon
suspect
caus
cdd
therefor
minim
invas
techniqu
develop
assess
transit
time
bovin
larg
intestin
cow
cdd
comparison
healthi
cow
cow
displac
abomasum
lda
local
primari
motil
disord
lead
cdd
cow
spontan
cdd
n
healthi
control
cow
n
cow
lda
n
includ
studi
five
polioxometal
capsul
contain
temperatur
sensor
electron
transmitt
introduc
lumen
ileum
cecum
proxim
loop
ascend
colon
plac
two
locat
spiral
colon
measur
transit
time
defin
time
implant
devic
intestin
abrupt
drop
measur
temperatur
indic
excret
transmitt
transit
time
differ
intestin
segment
compar
among
group
use
test
techniqu
transit
time
assess
bovin
intestin
safe
reliabl
high
variabl
transit
time
observ
intestin
segment
group
addit
output
sequenc
irregular
ie
capsul
implant
distal
intestin
segment
alway
excret
first
statist
analysi
reveal
signific
differ
p
transit
time
distal
locat
spiral
colon
among
group
cow
longest
median
time
cow
cdd
particularli
mark
variabl
prolong
transit
time
observ
calcul
transit
time
plac
proxim
locat
spiral
colon
cow
cdd
differ
among
group
signific
p
high
degre
variabl
observ
preclud
routin
use
transit
time
measur
indirect
assess
intestin
motil
cattl
howev
result
obtain
present
studi
allow
confirm
role
motil
disord
bovin
colon
pathogenesi
cdd
p
walz
edmondson
k
riddel
braden
j
gard
j
bayn
k
joiner
md
given
colleg
veterinari
medicin
auburn
univers
auburn
al
prebreed
vaccin
provid
fetal
abort
protect
reproduct
pathogen
imped
reproduct
object
assess
reproduct
perform
heifer
revaccin
viral
vaccin
prior
synchron
natur
breed
sixti
beef
heifer
randomli
assign
four
treatment
group
b
n
vaccin
express
fp
day
initi
detect
estru
revaccin
day
later
correspond
day
group
day
group
b
synchron
natur
breed
group
c
n
serv
control
vaccin
citadel
time
point
group
b
respect
estrou
behavior
assess
use
radio
frequenc
technolog
estru
synchron
perform
initi
occur
revaccin
group
c
day
revaccin
group
b
synchron
heifer
submit
bull
breed
pastur
day
end
breed
period
heifer
ultrasound
assess
pregnanc
progesteron
concentr
evalu
unsynchron
synchron
estru
day
later
initi
pregnanc
check
studi
end
vaccin
express
fp
result
signific
neg
reproduct
impact
base
upon
durat
interestr
interv
proport
heifer
exhibit
estru
within
day
synchron
serum
progesteron
concentr
pregnanc
rate
pregnanc
first
five
day
breed
season
use
express
fp
imped
reproduct
revaccin
perform
day
prior
synchron
natur
breed
byer
beemer
lear
r
callan
holt
colorado
state
univers
colleg
veterinari
medicin
biomed
scienc
fort
collin
co
purpos
studi
evalu
effect
differ
insulin
formul
glucos
concentr
evalu
use
continu
glucos
monitor
cgm
system
alpaca
six
healthi
alpaca
one
hospit
alpaca
util
studi
intraven
cathet
cgm
system
place
healthi
alpaca
regular
insulin
ukg
iv
sc
nph
insulin
ukg
sc
insulin
glargin
ukg
sc
dextros
mgkg
iv
administ
healthi
alpaca
week
period
follow
drug
administr
blood
sampl
collect
glucos
test
set
time
point
cgm
record
glucos
concentr
everi
minut
hospit
alpaca
also
cgm
system
instal
blood
sampl
collect
measur
glucos
concentr
period
data
compar
use
method
comparison
techniqu
error
grid
plot
anova
blood
glucos
valu
healthi
alpaca
decreas
rapidli
follow
regular
insulin
administr
compar
formul
nph
insulin
produc
longest
glucos
suppress
effect
lag
glucos
concentr
obtain
cgm
compar
whole
blood
alpaca
advers
reaction
differ
insulin
formul
due
prolong
durat
effect
nph
insulin
may
appropri
long
term
use
hyperglycem
alpaca
cgm
could
use
monitor
glucos
trend
reduc
blood
collect
event
howev
sole
method
determin
treatment
protocol
pd
j
anim
scienc
biosystem
engin
univers
tennesse
knoxvil
tn
veterinari
medicin
univers
wisconsin
madison
wi
dairi
calf
pneumonia
dcp
preval
econom
import
condit
affect
calv
andor
period
impact
dcp
extend
beyond
actual
diseas
episod
neg
effect
subsequ
product
surviv
replac
stock
abil
identifi
calv
initi
stage
respiratori
diseas
develop
difficult
object
monitor
activ
feed
behavior
may
allow
earlier
diseas
detect
intervent
potenti
decreas
consequ
dcp
later
calf
life
object
studi
identifi
earli
behavior
chang
respiratori
diseas
develop
young
dairi
calv
subject
differ
milk
feed
level
standard
high
hous
individu
group
holstein
calv
differ
commerci
dairi
farm
standard
milkindividu
hous
high
milkindividu
hous
standard
milkgroup
hous
use
studi
overal
respiratori
diseas
incid
approxim
social
interactionact
level
well
feed
behavior
measur
fit
calv
collar
contain
sensor
period
calv
screen
daili
clinic
sign
diseas
deep
pharyng
swab
obtain
sick
calv
detect
pathogen
associ
respiratori
diseas
pcr
serum
sampl
collect
serolog
autom
sensor
system
success
record
activ
level
calv
differ
farm
total
activ
level
correl
milk
consumpt
show
signific
increas
time
preced
feed
addit
uniqu
time
seri
signatur
correspond
normal
specif
behavior
sleep
stand
walk
andor
bottl
feed
establish
acceler
data
activ
level
use
data
identifi
deviat
norm
calv
respiratori
diseas
increas
activ
level
compar
healthi
cohort
conclus
result
suggest
calf
behavior
may
use
mean
diseas
detect
l
c
p
georgia
athen
institut
technolog
atlanta
ga
bovin
respiratori
diseas
brd
lead
caus
bovin
morbid
mortal
polymicrobi
infect
viral
bacteri
pathogen
common
brd
lead
sever
diseas
induc
singl
agent
infect
agent
first
encount
host
airway
epitheli
cell
speci
airway
epitheli
cell
influenc
host
immun
releas
cytokin
immun
cell
activ
role
bovin
bronchial
epitheli
cell
bbec
respons
brd
influenc
polymicrobi
infect
bbec
poorli
character
object
studi
determin
whether
express
cytokin
surfac
activ
marker
alter
bbec
bovin
respiratori
syncyti
viru
brsv
mycoplasma
bovi
mb
compar
respons
bbec
infect
either
agent
alon
bbec
isol
cattl
bronchial
brush
grown
differenti
interfac
cultur
cell
expos
media
mock
infect
pfu
brsv
cfu
mb
agent
togeth
hour
infect
confirm
immunofluoresc
microscopi
transepitheli
resist
ter
measur
infect
express
mrna
cytokin
interleukin
rant
adhes
molecul
quantifi
real
time
transepitheli
resist
decreas
cultur
hour
ter
increas
toward
baselin
mock
brsv
cultur
mb
mb
brsv
cultur
express
rant
increas
sharpli
hour
brsv
infect
suppress
mb
express
increas
brsv
mb
increas
coinfect
diseas
cattl
infect
brsv
mb
may
exacerb
impair
migrat
leukocyt
excess
neutrophil
influx
due
alter
express
rant
bc
credil
ar
woolum
dj
hurley
mw
overton
univers
georgia
colleg
veterinari
medicin
athen
ga
object
studi
determin
preval
bacteremia
dairi
cattl
acut
puerper
metriti
apm
determin
clinicopatholog
factor
associ
bacteremia
popul
anim
cow
examin
time
identif
apm
complet
blood
count
serum
biochem
analysi
bacteriolog
cultur
blood
lochial
fluid
perform
anim
time
diagnosi
sampl
collect
healthi
herdmat
similar
pariti
day
milk
blood
cultur
result
clinicopatholog
paramet
compar
group
condit
logist
regress
use
evalu
factor
associ
apm
multivari
logist
regress
use
evalu
factor
associ
bacteremia
bacteremia
occur
cattl
apm
control
bacillu
spp
organ
commonli
isol
bloodstream
cattl
group
bacterem
cattl
group
significantli
less
like
basophil
peripher
circul
like
higher
serum
globulin
concentr
bacteremia
common
occurr
dairi
cattl
like
bacteri
colon
involut
uteru
immunosuppress
system
inflamm
play
role
high
frequenc
bacteremia
studi
warrant
investig
mode
bacteria
colon
bloodstream
popul
anim
signific
bacteremia
health
product
affect
anim
g
clausen
kp
poulsen
j
vanega
neman
oregon
state
univers
colleg
veterinari
medicin
corval
despit
short
long
term
cost
respiratori
diseas
otiti
media
dairi
replac
heifer
calv
veterinarian
produc
still
lack
abil
effect
earli
identif
prognost
infect
calv
object
studi
use
advanc
imag
improv
establish
diagnost
techniqu
calv
diagnos
otiti
media
thirti
jersey
calv
enrol
three
group
n
per
group
singl
farm
respiratori
diseas
diagnos
farm
personnel
use
mcguirk
respiratori
score
system
calv
group
primari
diseas
primari
treatment
failur
multipl
treatment
failur
calv
transport
veterinari
medic
teach
hospit
oregon
state
univers
radiograph
thorax
skull
focus
tympan
bulla
obliqu
midlin
contrast
enhanc
comput
tomographi
ct
follow
imag
calv
euthan
submit
diagnost
patholog
calv
radiograph
compar
ct
imag
assess
lesion
tympan
bulla
use
gross
patholog
gold
standard
fluid
bulla
osteolysi
measur
use
score
system
bulla
wall
thick
directli
measur
comparison
differ
found
radiograph
ct
detect
fluid
bulla
radiograph
better
abl
quantifi
osteolyt
lesion
compar
ct
ct
better
abl
detect
boni
prolifer
bulla
wall
compar
radiograph
later
wall
thick
significantli
increas
treatment
failur
compar
ventral
medial
bulla
wall
thick
cm
group
respect
p
mycoplasma
bovi
cultur
calv
group
posit
calv
nasal
swab
posit
howev
lower
airway
bovi
cultur
group
group
neg
find
suggest
radiograph
imag
tympan
bulla
dairi
calv
otiti
media
suffici
detect
fluid
bulla
better
ct
quantifi
osteolysi
relev
clinic
manag
otiti
media
ct
avail
also
show
nasopharyng
swab
appropri
bovi
detect
calv
clinic
sign
otiti
media
